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ABSTRACT
Embryonic stem cells, with the ability of self-renewal and differentiation to generate cells
of all three germ layers, are promising sources to address developmental questions and also for
use in clinical regenerative medicine. Generating lineage-committed intestinal stem cells from
embryonic stem cells (ESCs) could provide a tractable experimental system for understanding
intestinal differentiation pathways and may ultimately provide cells for regenerating damaged
intestinal tissue. Intestinal organoids are multicellular crypt-like structures that can be derived
from isolated intestinal stem cells or from embryonic stem cells (ESCs) following described
differentiation procedures. In addition to their potential usefulness in tissue repair, intestinal
organoids may also be useful as tissue surrogates to study basic aspects of intestinal cell biology
and for the identification of novel compounds for intestinal diseases and disorders.
In this work, we first generated a two-step differentiation procedure in which ESCs were
first cultured with activin A to favor formation of definitive endoderm, and then treated with
fibroblast-conditioned medium with or without Wnt3A to generate intestinal organoids. The twostep differentiation protocol generated gut bodies with crypt-like structures that included regions
of Lgr5-expressing proliferating cells and regions of cell differentiation. The ability of the
definitive endoderm to differentiate into intestinal epithelium was supported by the vivo
engraftment of these cells into mouse colonic mucosa. These findings demonstrate that definitive
endoderm derived from ESCs can carry out intestinal cell differentiation pathways and may
provide cells to restore damaged intestinal tissue.

Li Cao – University of Connecticut, 2013

We next analyzed their cellular compositions of ESC-derived intestinal organoids under
different conditions. We found that the resulting organoids were enriched for intestinal stem cells
expressing intestinal stem cell markers Lgr5, Msi1, Tert and Dclk1, relative to cells stripped from
colonic mucosa. Similar to intestinal crypt cells, the Tert and Lgr5 expressing cells resolved into
two distinct populations. Under two different differentiation procedures, the intestinal stem cell
population was found to be largely unaffected whereas the expression of secretory vs. absorptive
cell genes could be altered. Finally, intestinal organoids derived from cancer-prone ApcMin/+ mice
showed reduced Atoh1 expression, as reported for native intestinal tissue, indicating that aberrant
differentiation signaling is reproduced in the organoid system. Our data support the use of ESCderived intestinal organoids as tissue surrogates for the study of early events in intestinal stem
cell differentiation. We propose that these organoids may be particularly useful for modeling
colonic mucosa at risk for cancer development.
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CHAPTER 1
GENERAL INTRODUCTION

Embryonic stem cells (ESCs) are undifferentiated cells derived from the inner cell mass
of the

blastocyst, which is the spherical structure formed in the early stage of embryo

development

1,2

. These pluripotent ESCs are characterized by their ability to self-renew and to

generate differentiated cells of all three germ layers including the endoderm, mesoderm and
ectoderm lineages 3. Due to the capabilities of self-renewal, proliferation and differentiation, the
ESCs have been studied to explore fundamental questions in developmental biology and used in
clinical regenerative medical research 4. Adult stem cells, also known as somatic stem cells, are
found in fetal and post-natal tissues or organs. The adult stem cells are infrequently cycling cells
that maintain the capacity to self-renew and differentiate into various cell types of the tissue or
organ from which they are derived under the regulation of appropriate signals 5. The stem cells
persist in specific microenvironments called niches that provide a protected environment and
produce essential factors to maintain the mitotically quiescent status and the ability to undergo
asymmetric division to generate active cycling daughter cells, or so-called progenitors. Once they
leave the niche, they proceed to differentiation 6. The induced pluripotent cells (iPSCs) are derived
from adult cells that were originally produced to avoid immunogenic responses, but even these cells
are immunogenic 7.

Although it is believed that stem cells can be used as potential sources of regenerative
applications, a number of stem cell based therapies are still in experimental stages due to technical
limits or costs. Recently, researchers developed cell culture protocols to generate multi-cellular
structures termed organoids. Intestinal organoids (IOs) are crypt-villus like structures generated from
human or mouse ESCs, iPSCs, and adult stem cells

8–10

. The ability of ESC-derived IOs to grow

quickly and in relatively large quantities make them a potential model for study of developmental

1

signaling, drug screening, understanding disease progression, and assessing potential treatments.
The work presented herein highlights the protocol we developed to generate IOs from ESCs,
and the analysis of genes expression in cells that make up the IOs. We also discuss the potential of
using IOs as tissue surrogates for intestinal epithelium related studies.

Intestinal Stem Cell
The small intestine and large intestine (colon) are two anatomically and functionally
distinct organs of the gastrointestinal tract. The major functions of the small intestine are to digest
food and absorb nutrients and minerals. Nutrients including proteins, lipids and carbohydrates are
degraded into small peptides/amino acids, fatty acids/glycerol, and monosaccharides by digestive
enzymes in small intestine. These nutrients are then absorbed through the mucosa of the small
intestine. The colon is the last part of the digestive system, which continues from the bottom end
of the small intestine. The colon absorbs water, mineral ions, and vitamins from the indigestible
residue of food.
The intestinal epithelium lining the gastrointestinal tract is a single layer cells consisting
of four subtypes of cells with specialized physiological functions to either serve as barriers
between the intestinal lumen and underlying sterile mucosa, or play a critical role in nutrient and
water absorption

11,12

. The intestinal epithelium is a rapid dynamic tissue with a turnover rate for

the entire epithelial lining every 3-5 days in adult mammals 12. Therefore, an efficient mechanism
is required to maintain homeostasis of intestinal epithelium. The intestinal stem cells (ISCs), with
the properties of self-maintenance and potential capacity to produce all cell lineages, have the
ability to supply new cells and repopulate the mucosa to support normal epithelial homeostasis
throughout life 13.
The first work that identified the existence of ISCs was carried out by a microcolony
experiment in 1970’s. In this study, single cells within the crypt survived after irradiation to
produce all cell types, and regenerated the whole crypt 14. The exact number and location of ISCs
are not established; however, there is a general agreement that approximately 4-6 independent
2

stem cells are located at base of the crypt. Researchers then generated two models of ISC identity
using genetic lineage tracing and transplantation experiments: (1) cell position 4 from the bottom
of the crypt, just above the Paneth cells, or (2) the small undifferentiated cycling cells called crypt
base columnar (CBC) cells interspersed between the Paneth cells in the base of crypt

13,15

. In +4

model of ISCs identity, ISCs reside directly above the noncylcing Paneth cells (+4 position on
average) and are radiation-sensitive, label-retaining and actively proliferating cells with a cell
cycle time of 24 hrs

13,16

. In the stem cell zone model, CBCs are characterized as radiation-

sensitive, non-label retaining and actively proliferating cells with a cycle time of 24 hrs. The adult
stem cell niche of the intestine is supported by proliferating epithelial cells and subepithelial
myofibroblasts, which produce proteins, growth factors and cytokines to maintain the stem cell
self-renewal and promote proliferation.
The luminal protrusions called villi and bottle-shaped invaginations called crypts are
structural and functional fundamentals of the intestinal epithelium lining in the gastrointestinal
tract. To continuously produce new intestinal epithelial cells, ISCs residing in the base of the
crypts generate transit-amplifying cells (TA cells) under the induction of specific signaling
molecules and migrate along the crypt-villus axis to differentiate to predominant absorption
enterocytes, mucus-secreting Goblet cells, and peptide hormone secreting enteroendocrine cells.
TA cells also migrate toward the bottom of the crypt and differentiate to a fourth cell type; the
anti-microbial compounds secreting Paneth cells 17. Defined cell markers play important roles on
identification and isolation of ISCs, and understanding the relationships between these markers is
a useful tool to elucidate the mechanisms of stem cell function and regulation. Some researchers
have suggested that Musahi-1(Msi1)
and Lgr5

22,23

18,19

, Dclk120, Telomerase Reverse Transcriptase (Tert)

21

,

could be potential ISC markers based on the knowledge of their localization,

abilities of crypt regeneration or organoid formation from single isolated cells.
Wnt signaling pathway

3

The Wnt genes are an evolutionarily conserved family of extracellular signaling
molecules which were initially found and named as Wng in Drosophila and Int1 in mouse. The
Wnt signaling pathway has been identified as an important pathway that controls diverse
processes in embryogenesis, adult tissue homeostasis, and disease development 24. During the
canonical pathway, a lack of the Wnt protein leads to β-catenin phosphorylation, ubiquitination
and degradation by glycogen synthase kinase 3 (GSK-3), adenomatous polyposis coli (APC), and
Axin complex, resulting in the inhibition of downstream gene expression. In the presence of Wnt
ligands, Wnt signaling proteins bind to the Frizzled/low-density lipoprotein receptor-related
protein (LRP) family receptors on the surface of target cells, scaffolding proteins Axin are
removed from the GSK-3/APC/Axin complex in cytoplasm, thereby inhibiting the proteasomemediated degradation of β-catenin in cytoplasm. The accumulated β-catenin in the cytosol then
enters the nucleus and interacts with the lymphoid enhancer-binding factor 1 (LEF)/T cell
specific transcription factors (TCF), and subsequently induces the transcription of target genes25.
The non-canonical Wnt signaling including the planarcell-polarity (PCP) pathway and Wnt/Ca

2+

pathway are important in cell movements during gastrulation and cell adhesion regulation 26.
The Wnt signaling components are expressed in a wide variety of tissues and are
implicated to play important roles in stem cell regulation, including cell proliferation,
specification, differentiation, and migration

27,28

. Recent research demonstrates that the Wnt

proteins (Wnt 2B, Wnt 3A, Wnt 5A, and Wnt 10B) and the Wnt receptors (Frizzled 6 and LRP-6)
are expressed in bone marrow cells enriched for hematopoietic stem cells (HSCs) and their niches,
indicating that HSCs can receive Wnt signaling

29

. Further evidence also suggests that Wnt

signaling promotes human and murine HSCs self-renewal, proliferation of undifferentiated
progenitors; increase the ability of reconstitution of hematopoietic system of irradiated mice by
HSCs and inhibit the differentiation in vitro. Conversely, deregulation of Wnt signaling pathway
by overexpression of Axin leads to inhibition of HSCs growth and loss the ability of
reconstitution of hematopoietic system of irradiated mice29. The Wnt signaling pathway also
4

plays crucial roles in development of the neural tube, proliferation of neural stem cells,
maintenance of the neural procursors, and cell fate determination in the nervous system

30

.

Researchers found that the function of Wnts vary with different tissue types and developmental
stages both in vitro and in vivo 31.
During the early stage of gastrulation, β-catenin is required to promote definitive
endoderm formation 32. Further evidence also shows that Wnt signaling is essential for gut tube
formation

33

. In the adult intestine, the Wnt signaling gradient decreases from the stem cell

compartment region located in bottom of the crypt to upper proliferative areas, and tailing off in
the differentiative areas 34. Loss of Tcf4, β-catenin, or overexpression of the Wnt inhibitor Dkk-1
leads to loss of transit-amplifying cells in intestine

35–37

, whereas mutations on APC or

overexpression of β-catenin result in hyperproliferation of the epithelium

38–41

.

Loss of

transcription factor TCF4 in the crypt leads to depletion of stem cells 35.
Normal level of endogenous Wnt signaling regulates intestinal homoeostasis, whereas
aberrant Wnt signaling causes intestinal tumorigenesis. Mutations in the Wnt pathway; such as
the loss of APC or gain of activated β-catenin, increase the level of stable β-catenin leading to
constitutive activation of the nuclear β-catenin/TCF transcription factor complex resulting in the
formation of colon polyps that can develop into carcinomas

42

. Given that the Wnt pathway is

important to several diseases, especially colorectal cancer, synthetic Wnt inhibititory compounds,
monoclonal antibodies and natural products have been tested for Wnt pathway inhibition.
However, only few of them (PRI724 compound, OTSA011 against Frizzled homolog, and a
plant-derived natural phenol) are included for the colorectal cancer prevention 43.
Notch signaling pathway
Notch signaling pathway is an evolutionarily conserved signaling pathway that regulates
cell-fate determination during development and adult tissue homeostasis

44,45

. Notch proteins, the

single-pass transmembrane receptors with multiple epidermal growth factor-like repeats followed
by conserved cysteine-rich Notch/Lin12 repeats and cdc10/ankyrin repeats, can interact with
5

ligands (Delta/Jagged) to trigger Notch signaling. After binding with ligands, the Notch
intracellular domain (NICD) is released by sequential proteolytic processing catalyzed by
ADAM-family metalloproteases and γ-secretase and translocates into the nucleus. NICD then
associates with a DNA binding protein CSL and its coactivator; Mastermind, to assemble a
transcription complex that activates the transcription of downstream target genes46–48.
In the intestinal epithelium, Notch pathway components including Notch ligands,
receptors, and the Notch target genes; Hes1 and Hes5, are restrictedly expressed in proliferating
crypts in different stages of differentiation and development

49–51

. Studies have shown that

activation of Notch signaling contributes to intestinal epithelial homeostasis by promoting
proliferation of ISCs/progenitor cells 52 and promoting the absorptive cell fate determination 52–54.
Notch inhibition led to the loss of crypt base columnar cell, thus reduced proliferation and
disturbed intestinal organoids formation. Notch inhibition also induced differentiation of
epithelial progenitors into all secretory cell types, with increasing number of enteroendocrine,
Paneth cells, tuft cells, as well as goblet cells 55.
Overexpression of Notch signaling has been observed during the carcinogenesis of
various cancers including colon cancer 56. Studies found that the upregulation of Notch signaling
target genes leads altered goblet cell differentiation and mucin formation in patients with colonic
precancerous conditions as inflammatory bowel diseases

57

. Increased expression of Notch

recepters, ligands, and downstream targets including Hes1, Deltex and NICD are also found in
colorectal cancer compared with normal colonic mucosa 58. Two Notch-targeting approaches, γsecretase inhibitors and small interfering RNA (siRNA)-mediated knockdown of Notch receptors,
notch ligands, and Notch downstream targets, have been studied for the colorectal cancer therapy
. γ-secretase inhibitors suppressed growth of colon cancer cell lines HT29 and HCT116, and

58

sensitized colon cancer cell lines to chemotherapeutic agent-induced cell apoptosis and growth
inhibition

59,60

. Studies also found that siRNA-mediated knockdown of Notch1 and Jaggled1

6

were able to inhibit cell proliferation and migration in colon-derived HT29 and HCT116 cell lines
59

.

ISC markers
Musashi-1
Musashi, an evolutionarily conserved neural RNA-binding protein, was first reported to
play essential roles in the development of adult external sensory organs (sensilla) in Drosophila
61

. It regulates target genes at the post-transcriptional level and controls asymmetric cell division

through the Notch signal pathway62. Mouse Musashi-1 (Msi1) has been proposed as an adult stem
cell marker in several mammalian organs including the nervous system63, hair follicles64, and
mammary glands65. In the mammalian nervous system, Msi1 represses synthesis of an
intracellular Notch antagonist m-Numb, thus activating the Notch signaling pathway to maintain
the undifferentiated state of mammalian neural stem cells66. In mouse intestinal epithelium, Msi1
positive cells are observed selectively expressed in few epithelial cells at the base of the crypt,
including cell position 4, the putative position of stem cells 18. Recent study revealed that Msi1positive cells derived from mouse ESCs, when hypodermically engrafted into the back of
NOD/SCID mice, can differentiate into neural and intestinal epithelial cells 19.
Dclk1
Doublecortin and CaM kinase-like-1 (Dclk1), a microtubule-associated kinase expressed
in post-mitotic neurons, has been recently identified as a putative ISC marker

67

. Dclk1

expression was observed in a limited number of gut epithelial progenitors within the stem cell
niche of the stomach and small intestine crypts

68

. Investigators then demonstrated that Dclk1-

expressing cells undergo apoptosis after 24 hours following 6 Gy of whole-body ionizing
radiation (IR), a p53-independent wave of apoptosis that primarily affects stem cells

67

. Dclk1

expressing cells were restored in the regenerative crypts 7 days after lethal dose of IR treatment,
and were not proliferating and therefore quiescent 67. Isolated single Dclk1 positive cells can form
spheroids in suspension culture, which when injected into nude mice induced nodular growths on
7

the flank with glandular epithelial and intestinal epithelial lineage commitment

20

.

Immunofluorescence microscopy and double immunostaining revealed colocalization of Dclk1
and Msi1 in the stem cell zone of crypt in adult mouse intestine indicating that Dclk1 and Msi1
are co-expressed in the subset of Msi1 expressing cells 67.
Lgr5
Lgr5, an orphan G-protein coupled receptor with a large leucine-rich-repeat extracellular
domain and seven transmembrane domain, was initially identified as a Wnt target gene in colon
cancer, and then was found expressed in other tissues like ovary and liver cancer

69–71

. The

expression of Lgr5 in the embryo is dynamic with a complex pattern. However, in adults, Lgr5
expression is detected in scattered cells in a variety of tissues including intestine, hair follicle,
eye, brain, mammary gland, reproductive organs, and stomach 72. Both heterozygous Lgr5-LacZ
knock-in mice and Lgr5-EGFP knock-in mice identified the Lgr5 restrictively localized at the
proliferative crypt bottom of intestine, especially in the columnar cells between the Paneth cells
22

. The genetic lineage tracing experiment also revealed that the Lgr5-positive cells have the

ability to self-renew, multiply, and generate the entire epithelium containing goblet cells,
enterocytes, enteroendocrine cells, and Paneth cells 72. Recently, scientists generated crypt-villus
organoids from single Lgr5 stem cells under long-term culture conditions. Four types of mature
epithelium cells derived from single stem cells were confirmed with normal morphology and
function

23

. Although the these findings suggest that Lgr5 serves as a stem cell marker of the

intestinal epithelium, the Lgr5-expressing cells are not quiescent with a cell cycling rate of once
per day 73.
Tert
Tert, known as telomerase reverse transcriptase, is a part of the telomerase complex
which controls telomere length and plays an important role in stem cell, aging, and cancer. β–
catenin regulates activity of Tert promoter in ESCs and adult stem cells, thus regulating the

8

expression of Tert in cells 74. Mouse telomerase reverse transcriptase (mTert) expressing cells
localize to single cells in the intestinal crypt, but distinct from ISCs expressing Lgr5. Unlike
rapidly cycling Lgr5-expressing cells, the mTert-expressing cells are slow cycling and mark
label-retaining cells (LRCs) within the intestine. mTert-exprssing cells are resistant to the
radiation, give rise to Lgr5-expressing cells 21.
Impact of this study

The constant turning over of the intestinal epithelium and lineage tracing experiments
have provided evidence that there are stem cells populations marked with several ISC markers,
including Lgr5, Tert, Dclk1, in the base of intestine crypts. Lgr5 expressing cells are actively
cycling cells, which have been identified to be CBC cells located between the Paneth cells at
positions +1 – 3 from the crypt base. These rapid cycling ISCs are relatively radioresistant 75, and
can generate all cell lineages of the intestinal epithelium over the lifetime of the animal 22. Unlike
the rapid cycling ISCs, slow cycling ISCs marked by Tert and other markers are positioned at
position +4 relative to the crypt base and were initially identified as DNA label-retaining cells21.
Although no present data shows co-localization of Lgr5 and Tert in the cells, inter-conversion
between Lgr5- marked cells and Tert marked +4 cells has been detected by lineage tracing
experiments

21

. The Dclk1 positive cells positioned in crypt base are quiescent, but isolated

single Dclk1 expressing cells can proliferate and generate glandular structures in the flanks of
athymic mice 67. However, unlike Lgr5 and Tert, Dckl1 expressions have been also detected in
mature Tuft cells 76. Dckl1 may therefore mark a differentiated cell type that can serve as a stem
cell pool under some circumstances. Co-expression of Dclk1 and Lgr5 has been detected in
some cells by in situ hybridization experiments

77

. Radiation-induced apoptosis studies have

provided evidences that there are multiple stem cell populations in the intestine. One possibility is
that they can all serve as stem cells under different conditions, for example, Lgr5-expressing
CBCs are considered as the primary source of cell renewal in the intestine epithelium, while the
9

+4 ISCs serve a stable source of slowly dividing cells

78

. The usefulness of these markers for

guiding the differentiation and lineage commitment of stem cells in culture is not yet clear, and
the precise relationship between cells expressing these ISC markers is not clear either. To evaluate
the potential of differentiating ESCs to intestinal lineages and to understand signaling pathways
involved in intestine development, we developed a procedure to generate intestinal lineage from
ESCs directly and tested the potential reparative capacity of definitive endoderm cells in the first
part of this study.
Recently, researchers have developed technology to generate IOs from mouse or human
isolated ISCs, iPSCs or ESCs

8–10

. These IOs are organized crypt-villus like structures and

comprised of ISCs and intestinal lineages of intestine. In addition, these IOs can be maintained in
defined medium for long term culturing

23

. Thus, the IOsare particularly useful as tissue

surrogates for determining the relationship between the ISCs expressing different markers and
studying events in the differentiation process. Unlike laborious, costly, and time-consuming
mouse models and transformed cell lines, generating and maintaining organoids are easily
manipulated, economic, and time-saving. ESC-derived IOs could be also applied for screening of
biological agents and small molecules to investigate signaling mechanisms that control the
growth and differentiation of intestine and uncover novel pharmacological targets. In addition to
the wild type ESC-derived IOs, organoids can be generated from ESCs of other genetic
backgrounds, which is specific facilitated to disease studies. However, the composition of ESCderived organoids under different culture conditions are not clear, especially their relation to
intestinal mucosa. In the second part of this study, we performed a detailed comparison of
composition of mouse ESC-derived intestinal organoids and intact mouse intestinal mucosa, and
characterized IOs under different growth conditions using single-cell transcript profiling.
In general, differentiation of ESCs to intestinal lineages in this study provides a technology to
generate and maintain intestinal organoids in culture system. The IOs can be employed for the
research on ISCs and early stages of differentiation. They may be useful tools for high throughput
10

screening for agents and small molecules in disease research in the future.

11

CHAPTER 2
MATERIALS AND METHODS

ESCs maintenance
C57BL6/N, GFP transgenic mouse ESCs (GlobalStem, Rockville, MD) and ApcMin/+
mouse ESCs were maintained on primary mouse embryo fibroblasts (MEFs) in DMEM media
supplemented with 15% fetal bovine serum (FBS), 1% nucleosides, 1% Pen-Strep, 1% nonessential amino acids, 1% L-glutamine, 1% β-mercaptoethanol and 1000 units/mL ESGRO®
(LIF) at 37 °C, 5% CO2 (table 1). All the reagents were Chemicon EmbryoMax ES Cell products
and purchased from Millipore Corporation (Billerica, MA). mESCs were checked and changed
medium, removed differentiated colonies daily mESCs were washed with PBS and passaged
using trypsin-EDTA as needed. H9 human ESC (WA09) were maintained on MEFs in DMEMF12 media supplemented with 20% knockout serum replacer, 1 mM (0.5%) L-glutamine, 0.1 mM
(1%) non-essential amino acids, 0.55 mM β-mercaptoethanol and 4 ng/mL bFGF (all from
Invitrogen) (table 1). Human ESCs were mechanically passaged using 1.0 mg/mL (1.0%)
collagenase (Gibco) and washed 3× with PBS prior to induction of differentiation.
Preparation of conditioned media
Mouse fibroblast L cells and L cells expressing Wnt3A purchased from ATCC (Manassas,
Virginia) (table 1) and maintained in complete growth medium containing DMEM medium
supplemented with 10% FBS and DMEM medium supplemented with 10% FBS with 0.4 mg/mL
G-418 respectively. Control conditioned medium and Wnt3A conditioned medium were prepared
according to the ATCC protocol. Briefly, 1:10 diluted cells are cultured in 10ml DMEM/FBS in
T75 flasks for 4 days. Carefully transfer medium from day 4 cultures and sterile filter, save at 4°C
as first batch of medium. Add fresh pre-warmed DMEM/FBS in the flasks and culture for another
3 days, collect and sterile filter the second batch of medium at day7 as above. Mix medium
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collected on day 4 and day 7 at 1:1 ratio, filter through 0.2 µm filter system, aliquot and save at 20 °C for future use.
Activin A induced differentiation and conditioned media- induced differentiation
Media and reagents not otherwise specified were purchased from Invitrogen (Carlsbad,
CA). Undifferentiated ESCs were separated from MEFs by panning in serum-free differentiation
media (SFD) containing 75% IMEM, 25% Ham’s F12 media supplemented with 0.5X N2
supplement, 0.5X B27 supplement, 1% Pen-Strep, 2 mM L-glutamine, 0.05% BSA (SigmaAldrich, St. Louis, MO), 0.5 mM ascorbic acid (Sigma-Aldrich), and 0.45 mM 1-thioglycerol
(Sigma-Aldrich) overnight. ESCs were then collected and re-suspended in SFD for two days to
form embryoid bodies (EBs). Activin A (R&D systems, Minneapolis, MN) was supplemented in
SFD to a final concentration of 50 ng/mL on day 2 and day 4 when changing the medium.
Definitive endoderm EBs were either harvested on day 6 or subjected to further treatment to
generate intestinal organoids.
Definitive endoderm EBs were transferred into 50 mL tube and settled down via gravity,
wash three times with PBS before further treatment in different conditions: 1) 30% Wnt3A
conditioned media (Wnt CM) with medium changed every four days; 2) medium containing 500
ng/ml Wnt 3A and 500 ng/ml FGF4 for four days followed by intestinal organoid media
supplemented with 500 ng/ml R-Spondin1, 100 ng/ml Noggin and 50 ng/ml EGF (IOM). The γsecretase

inhibitor,

N-[N-3,5-Difluorophenacetyl]-L-alanyl-S-phenylglycine

Methyl

Ester

(DAPM; Calbiochem, San Diego, CA) was used from day 12 to day 14 at a final concentration of
10 μM as needed.
Differentiation of H9 was initiated under serum-free induction conditions for 2 days in
RPMI1640 media (Gibco) containing GlutaMAX (Invitrogen), 100 ng/mL activin A (R&D
Systems), and 25 ng/mL Wnt3A (R&D Systems, Minneapolis, MN) to induce expression of
mesendoderm markers as Zorn and Wells79. Removal of Wnt3a and addition of 0.5% FBS and the
PI3kinase inhibitor LY294002 (Biomol, Plymouth Meeting, PA) for 2 additional days induced
13

definitive endoderm gene expression and repression of extra-embryonic endoderm markers as
McLean et al.80.
Real-time quantitative PCR
Total RNAs were extracted using TRIzol® Reagent (Invitrogen, Carlsbad, CA) following
the manufacturer's instruction. cDNAs were synthesized with high capacity cDNA reverse
transcription kit (Applied Biosystems, Foster city, CA) and stored at −20 °C until using. TaqMan
gene expression assays were purchased from Applied Biosystems (Table 2). A 10 μl reaction
mixture containing Taqman 2X PCR master mixture, 80 ng cDNA, and 2 μl Taqman gene
expression assays was prepared for real-time quantitative PCR. Reactions were performed for 40
cycles (50 °C 20 s, 95 °C 15 s, and 60 °C 1 min) using an Applied Biosystems 7300 Fast Realtime PCR system.
Animals
Male C57BL/6 mice were purchased form Taconic (Germantown, NY, USA). Mice were
maintained in a temperature-controlled, light-cycled room, and allowed free access to drinking
water and standard diet (LM-485, Harlan Teklad). Animals were weighed every day and mice
were checked daily for signs of weight loss or lethargy indicating intestinal obstruction or anemia
associated with tumors. Animal experiments were conducted with approval from the Center for
Laboratory Animal Care committee, University of Connecticut Health Center.
Induction of experimental colitis
Dextran sulfate sodium (DSS, MW 36 000–50 000) was purchased from MP Biomedicals
(Solon, OH). Mice were administrated 2% (w/v) DSS in drinking water for 1 week, starting 7
weeks age.
Intracectal engraftment of definitive endoderm cells
Mice were fasted for 18 h after colitis induction, and then anesthetized with
intraperitoneal injection of Avertin (Sigma-Aldrich). Definitive endoderm bodies (day 6) were
dissociated to single cells by Accutase (Millipore, Billerica, MA) after washing with DPBS twice
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and resuspended in DPBS to a final density of 5×107 cells/mL. Definitive endoderm single cells
(2×106 cells/40 μl/mouse) were injected intrarectally with a micropipette inserted through the
anus. Mice were monitored daily for weight loss, bleeding, and rectal prolapse during the entire
experimental period.
Frozen section
Mice were sacrificed by CO2 asphyxiation at 12 days after the cell injection. The entire
colon were harvested and flushed with ice-cold PBS and excised longitudinally. Specimens were
then fixed flat in freshly prepared 4% paraformaldehyde (PFA) at 4 °C for 1 h and stored in PBS
overnight at 4 °C, followed by cryoprotection in 30% sucrose at 4 °C until frozen sectioning.
Colon specimens were embedded with OCT and frozen in pre-cooled isopentane in liquid N2.
Ten-micrometer sections were cut and transferred on plus charged slides to check GFP-labeled
definitive endoderm cells. Slides with colon frozen sections were washed in PBS for 10 min,
followed by MgCl2 (10 mM in PBS) for 15 min, and then washed again in PBS for 10 min. The
slides were mounted with glycerol in PBS (50%). GFP were detected and imaged with an
Olympus epiflourescent microscope.
Immunofluorescence procedure
Immunofluorescence was performed for ID2, α-smooth muscle actin (αSMA), β-catenin,
LGR5, TFF3, and PCNA staining on paraffin embedded tissue sections of gut bodies and on the
frozen tissue section of mice colon. All antibodies were obtained from Santa Cruz
Biotechnologies (Santa Cruz, CA), except aSMA and LGR5, which were obtained from Abcam
(Cambridge, MA). Gut bodies formed were fixed in 70% ethanol, embedded in HistoGel
compound and later processed for paraffin sections. The tissue sections were deparaffinized and
placed in Citrate buffer (10 mM pH 6.0, 0.05% Tween-20), preheated to 90–100 °C for antigen
retrieval for 20 min. Normal goat serum was used to block non-specific binding for 30 min. The
sections were incubated overnight at 4 °C with primary antibodies ID2 (1:100 dilution), αSMA
(1:200 dilution), β-Catenin (1:150 dilution), LGR5 (1:200 dilution), TFF3 (1:100), Atoh1 (1:100
15

dilution), and PCNA (1:100 dilution). ID2, TFF3, and αSMA were coupled with Cy3 conjugated
Goat Anti-Rabbit immunoglobulin, PCNA with Cy3/FITC conjugated Goat Anti-mouse
immunoglobulin and β-catenin with Cy3 conjugated Donkey Anti-goat at 1:500 dilution in 0.01
M PBS containing 10% sodium azide for 30 min. All the secondary antibodies not otherwise
specified were purchased from Jackson ImmunoResearch Laboratories, Inc. (West Grove PA).
The frozen sections of colon were fixed in 4% PFA for 15 min followed by incubation in 70%
ethanol for 1 h. After washing with 0.01 M PBS, the slides were placed in citrate buffer for
antigen retrieval as described above. After blocking with normal goat serum, the slides were
incubated overnight at 4 °C with PCNA. It was coupled with Cy3 conjugated Goat Anti-mouse
immunoglobulin at 1:250 dilution in 5% goat serum. In both the procedures, nuclei were stained
with DAPI (Invitrogen Carlsbad, CA) at a 1:100 dilution for 10 min and the images were
captured using an Olympus epifluorescent microscope.
Alcian blue staining was performed to visualize goblet cells in colon tissue. Slides were
fixed in 4% PFA and then in 70% ethanol as described above, and then followed the standard
procedure for Alcian blue staining.
Single cell preparation and transcript analysis
All the TaqMan ® assays were purchased from Applied Biosystems (Table 1).
Definitive endoderm and intestinal organoids were incubated with Accumax with gentle
trituration every 5 min until dispersed into single cells. Single cells were gently pelleted, washed
with cold PBS, and then diluted in chilled serum free medium with propidium iodide (50 µg/mL
stock) to stain dead cells. Keep cells in this solution at 4°C protected from light until sorting by
the flow cytometer. Single cells were collected via fluorescent activated cell sorting (FACS) to
96-well plates containing 5 µl lysis solution (0.5 µl 5% NP-40, 0.5 µl RNAsin plus, and 2 µl 0.2
X pooled TaqMan ® assay in PBS). Cells lysates were obtained by incubating the plate at 70°C
for 10 minutes, followed by cooling at 4°C. Five microliters reverse transcription mix containing
5 nmol dNTPs, 100U MMLV reverse transcriptase, and 0.5 μL RNAsin plus was added to the
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lysate in each well for the reverse transcription reaction using the program (37°C/2 min, 42°C/1
min, 50°C/1 sec) for 40 cycles, followed by 85°C for 5min and a 4°C hold. Four microliters of
each cDNA prep were transferred to new 96-well plate, mixed with PreAMP mixture consisting
of 10 µl PCR Master Mix (Takara), 5 µl 0.2X Taqman Pooled Assay, and 1 µl MilliQwater. Preamplification was performed using an initial temperature cycle of 95°C/3 min, 55°C/2 min,
72°C/2 min, followed be a temperature cycle of 95°C/15 sec, 60°C/2 min, 72°C/2 min, for 16
cycles, followed by a 4°C hold. Two microliters of a 20-fold dilution of pre-amplified cDNA, 2 µl
of 5X TaqMan® gene expression assay, 5.0 μL 2X TaqMan® Universal PCR Master Mix, and 1
μL ddH2O were mixed for a standard real-time Quantitative PCR using program (50°C/20 sec,
95°C/10 sec), followed by 40 cycles of (95°C/15 sec, 60°C/10 sec) using an Applied Biosystems
7900 Fast Real-time PCR system.
Single cell data analysis
Single cell qPCR data were processed as previously reported. Briefly, single-cell cycle
threshold values (CT) from qPCR were used to normalize and cluster our data based on gene
expression profiles. Normalization was achieved via conversion to dCT in reference to internal
house-keeping gene values for each cell. Undetermined CT were set to be 40. All dCT values
were reversed to obtain positive values (dCT*) directly proportionate to gene expression levels
using the equation dCT* = 40 − dCT. Gene expression profiles were subjected to hierarchical
clustering based on dCT* using JMP software.
Statistic
Bulk RNA data was analyzed using a Student’s t test for comparing two treatment groups,
or by using an analysis of variance test (ANOVA) when comparing more than two groups. A
Tukey’s post-hoc test was employed to determine the significance of differences between multiple
groups, with p < 0.05 considered significant. The Fisher’s exact test was employed to analyze 2 X
2 contingency tables to determine gene expression frequencies in different cultures. A chi-square
analysis was performed to compare observed and expected frequencies of mRNA co-expression.
17

A probability of less than 0.05 was considered significant for these two tests.
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Table 1. Cell lines used in this study.

19

Table 2. Markers used in this study.
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Table 2. Markers used in this study. (Cont.)

21

CHAPTER 3
INTESTINAL LINEAGE COMMITMENT OF EMBRYONIC STEM CELLS

INTRODUCTION

The intestinal epithelium is a highly dynamic tissue constituted of a number of
specialized epithelial cells characterized by high rates of cell turnover

81

. In addition, the

intestinal mucosa is highly active immunologically, with epithelial cells playing a critical barrier
function and facilitating the movement of antigens, antibodies, and anti-microbial proteins into
and out of the intestinal lumen

82

. There are many instances in which damage to the intestinal

epithelium leads to a breakdown in its digestive, absorptive, and barrier functions. These include
conditions such as ulcerative colitis, Crohn’s disease, and celiac disease, as well as damage
induced by radiation and chemotherapies. Developing new approaches to save or restore
intestinal tissue could therefore find a broad range of applications.

During embryonic development the early gut tube is comprised of an endodermal cells
surrounded by visceral mesoderm 79. The endoderm differentiates into the epithelial lining of the
gut, while mesodermal cells ultimately develop into smooth muscle and other cell types of the
intestinal wall. Signaling between the mesoderm and endoderm in the developing gut through
Hedghog, Wnt, FGF, and other pathways helps establish anterior/posterior patterning and the
radial differentiation characteristics of the gut 22,82–85. Within the adult intestine, epithelial cells are
maintained through the presence of stem cells located within epithelial crypts 34,82,85. The survival,
proliferation and multipotency of adult ISCs are maintained in a niche region where trophic
factors are provided by adjacent mesenchymal cells, notably subepithelial myofibroblasts72,86. The
ISC niche supports active production of Wnt ligands, which play a central role is maintaining
intestinal epithelium. A better understanding of how the intestinal epithelium is generated and
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maintained could provide important insight into how this tissue might be effectively repaired and
restored following damage induced by chronic inflammatory conditions or cancer therapy.

Cell turnover and lineage tracing analyses have identified stem cell populations within
the intestinal crypts. These cells can be identified by their expression of a number of markers,
including Lgr5. Lgr5 was first identified as potential ISC marker by virtue of its regulation by the
Wnt/APC/ β-catenin pathway 87. It was subsequently shown to be expressed in a limited number
of columnar cells present at the crypt base, and lineage tracing supports the view that Lgr5
activation preceded cellular differentiation to all epithelial cell lineages

22

. Moreover, isolated

Lgr5-positive cells from the intestine can give rise to crypt-like structures in culture

23

. Other

markers that have been put forward as ISC markers include Msi1, Ephb2, and Dclk120,67,84,88–90.
All of these proteins are expressed in cells near the base of the crypt. Interestingly, while Dclk1positive cells have been shown to generate glandular epithelial structures in athymic mice, they
are quiescent within the crypts whereas Lgr5 cells are proliferative. The usefulness of these
markers for guiding the differentiation and lineage commitment of stem cells in culture is not
entirely clear.

An important goal for generative biology is to understanding signaling pathways
involved in tissue development and maintenance, and then exploit this knowledge to generate
cells for tissue and organ repair. Since gut epithelial cells are derived from embryonic endoderm,
we were interested in determining whether directing ESC development to an endodermal lineage
could provide a source of cells for generating intestinal tissue. Here we provide evidence that
induction of endoderm differentiation results in activation of the ISC marker Lgr5, but not Dclk1,
Msi1, or Ephb2. Interestingly, exposure of these cells to fibroblast conditioned medium with
Wnt3A promotes the expression of the other stem cell markers, and leads to the expression of a
range of genes associated with early intestinal development. In addition, the endoderm cells we
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generate are capable of associating with mouse intestinal mucosa and forming crypt-like
structures. These characteristics are consistent with intestinal lineage commitment and a potential
reparative capacity of these cells. We propose that endoderm-committed cells are primed to
generate mucosal tissue and are therefore well-suited to study this differentiation pathway. These
cells may ultimately be useful for repairing damaged intestinal tissue resulting from various
pathologies and treatments.

RESULTS

Early gut markers in definitive endoderm

Since the embryonic gut tube is derived from endodermal cells, we assessed the potential
usefulness of ESC-derived definitive endoderm for producing ISCs. Definitive endoderm
originates during gastrulation from early mesendoderm, which is generated in response to nodal
signaling emanating from the anterior region of the primitive streak. Activin A is a member of the
TGF- β superfamily that has been shown to mimic nodal and promote definitive endoderm
differentiation from ESCs in culture (Fig. 3.1A)

20,87

. We assessed the effectiveness of activin A

treatment of mouse ESCs under serum free conditions for generating definitive endoderm. As
shown in Fig. 1C, expression of the definitive endoderm markers Cxcr4, Sox17, Foxa2, and Gsc
were significantly increased following activin A treatment, whereas the stem cell markers Pou5f1
and Nanog were both significantly decreased (Fig. 3.1B). To determine the potential of these cells
to become intestinal epithelium, we determined the expression of a number of genes expressed in
the early embryonic gut. Fig. 3.1D shows the expression levels of a series of gut transcription
factors arranged in order of appearance during embryogenesis 91. Sox17, Foxa2, and Gata4 were
expressed in the definitive endoderm, whereas Id2 was not. As discussed below, Id2 is activated
later than the other markers (E9), possibly accounting for its lack of activation in the definitive
endodermal cells 20,91.
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A number of genetic markers have been employed to identify adult ISCs. We assessed the
expression level of four genes associated with the ISC for their activation following cell
differentiation to definitive endoderm. We found that of the four genes tested, only Lgr5 increased
following conversion to endoderm, whereas no significant change in Msi1, Ephb1, or Dclk1
expression was observed (Fig. 3.1C).
To determine if human ESCs responded similarly to the activn A differentiation
procedure, the human H9 ESC line was subjected to this protocol (Fig. 3.2A). As shown in Fig.
3.2B, the Pou5f1 and Nanog stem cell markers were decreased upon conversion to definitive
endoderm whereas all the definitive endoderm markers were activated (Fig. 3.2C). In addition,
the gut transcription regulatory proteins were all increased except for Id2, suggesting a
progression similar to that observed in the mouse stem cells (Fig. 3.2D). As in mESCs, the ISC
marker Lgr5 was activated upon endodermal differentiation whereas the other ISC markers were
unchanged (Fig. 3.2E). These data indicate that the human cells respond similarly to the mouse
ESCs with regards to this endodermal differentiation pathway.
Wnt stimulation of definitive endoderm
The ISC crypt is supported by mesenchymal cells that generate Wnt ligand, growth
factors, and other signaling molecules that promote ISC survival, proliferation and differentiation
86,92

. We therefore determined the impact of fibroblast-conditioned medium on the definitive

endoderm cells, using conditioned medium from control fibroblasts or transgenic fibroblasts
expressing Wnt3A (Fig. 3.3A). When the gene expression pattern of the early gut markers was
analyzed, it was found that expression of Sox17, Foxa2, and Gata4 was either maintained or
slightly enhanced following treatment with Wnt3A containing conditioned medium (Fig. 3.3B).
In addition, the conditioned medium treatment resulted in activation of the later gut marker Id2,
with the Wnt3A-containing medium working more efficiently that the control medium (Fig.
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3.3B). To obtain further evidence for the generation of intestine-like endoderm, we determined
the expression levels of Cdx2 and Fabp2, which are activated in the mouse at embryonic days 8.5
and 15, respectively

80,89,93

. Both markers were found to be activated to approximately the same

level in control conditioned medium and Wnt3A conditioned medium (Fig. 3.3C). Since Fabp2
expression indicates differentiation into an absorptive cell phenotype, we also checked whether
cells within these bodies had the potential to differentiate into a secretory lineage. As shown in
Fig. 3.3D, the Muc2 gene, which encodes a mucin protein, was expressed 4 days after Fabp2 is
detected. The expression of Muc2 could be enhanced by treatment with the γ-secretase inhibitor,
DAPM, which is consistent with Notch signaling limiting secretory cell differentiation in the
embryoid bodies.
We next determined the influence of conditioned medium on the expression of the ISC
markers. Lgr5, which was activated during the differentiation to definitive endoderm, was largely
unchanged following exposure to conditioned medium (Fig. 3.3E). However, treatment with
conditioned medium lead to the activation of three other marker genes associated with the stem
cell compartment: Msi1, Epbh2, and Dclk1. Activation of Ephb2 expression was enhanced by the
presence of Wnt3A whereas Msi1 and Dclk1 were not.

Activation of mesoderm markers by conditioned medium

The developing gut features extensive crosstalk between the endoderm and mesoderm
associated with the developing gut tube. We therefore performed a biomarker analysis to
determine whether there was any indication of gut mesoderm development in the cultures. For
this analysis we selected markers associated with the distal GI tract development in the mouse:
Foxf2, Hlx, and Hoxd8

22,83,94,95

. As shown in Fig. 3.3F, all three markers were activated by

conditioned medium and all three were enhanced by the presence of Wnt3A. These data suggest
the generation of both endodermal and mesodermal tissues in this differentiation protocol.
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Gut body formation in Wnt3A treated definitive endoderm

Fig. 3.4A shows representative colonies of ESCs, definitive endoderm, and Wnt3Aexposed definitive endoderm. A common change observed in the Wnt3A-treated endoderm was
the formation of a distinct, phase-dark periphery. The structures formed were reminiscent of gut
bodies previously reported to form from differentiating embryoid bodies 67,96. In addition, some of
the bodies displayed periodic contractions, much like the peristaltic action associated with gut
bodies (data not shown). This finding suggested the formation a smooth muscle component. To
further study the structural characteristics of the spheroid bodies formed following Wnt3A
stimulation, cells were fixed, sectioned, and analyzed by immunofluorescence. As shown in Fig.
3.4B, the general gut transcription regulator Id2 stained most of the cells within the spheroids 91.
In addition, some cells at the periphery of the spheroids were positive for smooth muscle actin,
consistent with the inclusion of a mesodermal layer in these structures (Fig. 3.4C).
A characteristic feature of intestinal epithelium is a gradient of β-catenin, with cells at the
crypt base expressing higher levels relative to mature cells. The gut organoids generated in
culture maintain a similar gradient, with higher β-catenin levels in cells at the periphery (Fig.
3.5A). We also assessed locations of cell proliferation within the structures by staining with
PCNA to determine if proliferative regions were structured as they are in the intestinal mucosa.
Fig. 3.5B shows two common arrangements of cell proliferation, with proliferating cells clustered
at the edges of the sphere (left panel) or with small clusters of proliferating cells within the sphere
(right panel). Regions of cell proliferation can sometimes form small outcrops containing clusters
of proliferating cells, reminiscent of the intestinal organoid cultures formed by Lgr5-positive cells
isolated from the small intestine

23

. The spheroid and out-cropping arrangements formed are

shown as bright field images of unsectioned organoids (Fig. 3.5C). To determine how Lgr5
expression related to regions of cell proliferation, immunostaining for Lgr5 and PCNA was
performed. As shown in Fig. 3.5D, there are discreet regions of elevated Lgr5 expression, which
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corresponded to regions of cell proliferation. Finally, to view the spatial relationship between
zones of cell proliferation and cell differentiation, sectioned organoids were immunostained for
PCNA and the goblet cell protein TFF3. Fig. 3.5E shows two representative crypt-like regions,
with proliferating cells present at the base of the crypts and the red-punctuate TFF3 staining
appearing in secretory vesicles of cells adopting goblet cell characteristics. This arrangement of
cells is similar to that found in intestinal crypts.

Introduction of definitive endoderm into the mouse colon

Since the definitive endoderm was found to express the Lgr5 stem cell marker, and could
be introduced to express other genes associated with intestinal development, we determined
whether these cells had the ability to associate with mouse intestinal mouse epithelium and
assume a crypt-like structure. For these studies, mouse ESCs expressing GFP were introduced
into the colon through the rectum of B6 mice that had been treated with DSS to denude portions
of the epithelium, since this procedure has been shown to promote cancer cell association with the
intestine 97. Twelve days after introduction of the cells, colons were isolated, fixed, and frozen.
Frozen sections of rolled tissue were then prepared and checked microscopically for green
fluorescent cells. A number of regions were observed in which isolated groups of green
fluorescent cells were observed (Fig. 3.6A). In addition, a number of regions were identified in
which GFP-labeled cells appeared to incorporate into crypts, primarily within the crypt base (Fig.
3.6B). To determine if the incorporated cells were capable of proliferation, a serial section of a
GFP-labeled crypt was analyzed for PCNA expression. PCNA expression was found to overlap
with cells expressing GFP, indicating that donor cells within these crypts were proliferative (Fig.
3.6C). To determine if cells within the incorporated crypts were capable of generating
mucopolysaccharides, Alcian blue staining was performed on a serial section of a GFP-expressing
crypt. This analysis indicated that cells within the GFP-labeled crypts were capable of expressing
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mucin, consistent with an ability to differentiate toward a secretory cell lineage (Fig. 3.6D).

DISCUSSION

The directed differentiation of pluripotent cells to an intestinal lineage could provide a
valuable experimental system to address important issues in developmental biology. In addition,
these cells may ultimately be useful for repairing intestinal mucosa damaged by inflammation,
radiation, or chemotherapeutic agents. We therefore assessed the potential of definitive endoderm
generated from ESCs to commit to an intestinal lineage. Stem cell-derived definitive endoderm
expressed a series of transcriptional regulatory genes found in the endoderm of day 8.5 (E8.5)
mouse embryos. Specifically, Sox17, Foxa2, and Gata4 are expressed in the endoderm, whereas
Id2, which is activated at day 9 was not

91

. At E9, the early gut tube is formed juxtaposed to

visceral mesoderm. Further treatment of the stem-cell derived endoderm with fibroblast
conditioned medium resulted in the appearance of the later embryonic markers Cdx2, Fabp2, and
Muc2 98. In the mouse, Fabp2 is expressed most robustly in the jejunum but also appears in the
duodenum and colon. The appearance of these markers in our differentiated cells suggests that
stem-cell derived endoderm have the ability to generate intestinal epithelium. Additional evidence
for the formation of intestinal epithelium comes from the analysis of cell proliferation and Lgr5
expression; PCNA and Lgr5 expression co-localize to discreet regions of the organoids, forming
structures reminiscent of intestinal crypts. Finally, the formation of functional intestinal
epithelium is supported by the finding that the cells can associate with the intestinal mucosa of
adult animals, and form crypt-like structures.

The intestinal epithelium is constantly turning over and stem cells present at the base of
the intestinal crypts generate new cells to populate the tissue. Several biomarkers have been
proposed to identify stem cells within the intestinal mucosa. In this study we examined the
expression of four ISC markers: Msi1, EphB2, Dclk1, and Lgr5. Msi1, the mammalian homolog
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of the Drosophila Musashi protein, was one of the first proposed ISC markers. Msi1 is expressed
in mammalian neural progenitor stem cells where it plays a key role in regulating cell potency
23,63,90,99–102

base

. In the intestine, Msi1 is expressed in cells above the Paneth cells and within the crypt

23,63,100

. The second marker we examined was the Ephb2 ephrin receptor, which is likewise

expressed by cells within the stem cell compartment where it plays an important role in
promoting cell proliferation in the niche region

103

. The third stem cell marker we examined,

Dclk1, is expressed in a limited number of slowly dividing cells within the crypts

104,105

. Isolated

Dclk1 cells form gland-like structures in the flanks of athymic mice, supporting their epithelial
progenitor capacity. Finally, the Lgr5 gene was originally identified as a Wnt-responsive gene
expressed in columnar cells at the base of the intestinal crypts22. Lineage tracing experiments
indicate that all epithelial cells within the crypt are derived from Lgr5-expressing cells. In
addition, isolated Lgr5 positive cells can form crypt–villus organoids when cultured ex vivo
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.

The precise relationship between cells expressing these different stem cell markers is not yet
clear. One possibility is that they can all serve as stem cells under different conditions. Radiationinduced apoptosis studies are consistent with the presence of multiple stem cell sources in the
intestine, with up to 32 stem cells potentially serving as a crypt stem cells when necessary106–109.
Whether the cells with differing sensitivity to radiation are distinct pools of cells, or whether they
are inter-convertible, is also not presently clear. Our in vitro differentiation procedure shows that
Lgr5 expression precedes that of the other stem cell markers. This finding is consistent with Lgr5
serving to mark the most primitive cell type committed to an ISC lineage. We propose that the
cells expressing the other stem cell markers are derived from these Lgr5 positive cells, and retain
the ability to contribute to crypt development. The differentiation procedure we describe here
should be particularly useful for determining the relationship between the cells expressing
different ISC markers, and the signaling pathways involved in regulating stages in their
development.
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ISC reside in a niche in which myofibroblasts generate Wnt and other growth regulatory
factors to promote the survival and proliferation of the stem cells

84,88,97,98,110,111

. Since Wnt

signaling plays an important role in promoting cell proliferation in the intestine and colon, we
initially reasoned that treatment of definitive endoderm with Wnt ligand would promote the
expression of Lgr5 and the other stem cell markers. Interestingly, we found that Lgr5 was
expressed in definitive endoderm prior to Wnt exposure. In addition, we found that fibroblast
conditioned medium in the absence of Wnt3A was sufficient for inducing expression of the other
ISC markers. In hindsight, this finding should not be too surprising given the fact that Wnt
signaling in early development is “reversed”, with robust signaling occurring in the maturing villi
(where it promotes differentiation), and little activity at the proliferating base 112. The requirement
for Wnt signaling in promoting ISC proliferation and survival may therefore occur at a
developmental time point later than what is modeled in our in vitro differentiation procedure.

Although expression of most of the intestinal epithelial markers was not stimulated by
Wnt3A, all the mesodermal markers tested were. The mesoderm in these cultures may serve to
guide the differentiation of the gut bodies, since the expression of the mesoderm markers
corresponded with an increase in the number of gut bodies actively performing peristalsis. Our
findings suggest that Wnt may play an important role in the development of mesenchymal
component of the lower gut. It is well-established that the inhibition of Wnt signaling in early
development leads to a shortened intestine, and this could result in part from deficiencies in the
growth of the mesenchymal portion of the tissue

113,114

. However, analysis of β-catenin activity in

the mesoderm has failed to provide evidence of canonical Wnt signaling in this portion of the
developing tissue

94

. If Wnt signaling is important for the development of the splanchnic

mesoderm in the lower GI tract, it is either occurring indirectly or it involves signaling through a
non-canonical Wnt pathway. An indirect mechanism might be one in which Wnt activates the
endoderm to express factors (such as hedgehog ligands) that promote the differentiation of the
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mesoderm 94. The differentiation procedure described here should provide a tractable model that
could generate important insight into the mechanism by which Wnt signaling stimulates the
differentiation of mesoderm into distal-gut tissue.
A potential clinical application of the differentiation procedure described here includes
generating cells that can populate, protect, and restore damaged intestinal tissue. As predicted by
their developmental potential when grown in culture, GFP-expressing, Lgr5-positive endoderm
cells can associate with intestinal tissue and form crypt-like structures. These structures possess
proliferating cells, and appear to include goblet cells. Whether these are fully functional crypts is
not entirely clear. For instance, the GFP labeled cells appear to reside primarily at the crypt base,
and we have not yet observed their extension to the surface of the tissue. In addition, the
engraftment efficiency of these cells is low, with less than one incorporation event observed per
animal (on average). Nonetheless, the ability of these cells to incorporate into the tissue is a first
step towards the development of these cells for potential therapeutic uses. The practical value of
cell-based therapies is supported by the recent finding that mesenchymal stem cells can promote
repair of DSS-induced colonic ulceration

66,115,116

. Providing both ISCs generated from ESCs or

IPS cells, and mesenchymal stem cells to damaged tissue is likely to provide the most effective
means of repairing damaged intestinal tissue.
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Figure 3.1. Activin A induced definitive endoderm differentiation from mouse ESCs.
(A) Schematic of the cell culture protocol used to induce mouse ESC differentiation into
definitive endoderm. This protocol employed activin A (50 ng/mL) treatment in serum free
differentiation medium (SFD). (B–E) Relative expression of mRNA markers in the definitive
endoderm cells (DE) relative to the mESCs. The mean of triplicate experiments are shown
(±standard error). (B) Decreased expression of pluripotency markers Pou5f1 and Nanog in DE.
(C) Definitive endoderm markers were increased following the treatment scheme shown in 1A,
relative to mESCs. (D) The expression of transcription factors in the digestive tract of mouse
embryos, arranged in order of their appearance during mouse embryogenesis. Sox17, Foxa2, and
Gata4 were significantly increased in expression, whereas Id2 was not. (E) Markers of adult ISCs
were determined for their activation following the differentiation procedure. Lgr5 was the only
ISCs marker activated in the definitive endoderm cells. All gene expression changes shown in this
figure were statistically significant (p<0.01, Student’s t test), with the exception of Id2, Dclk1,
Msi1, and Ephb2, which were unchanged.
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Figure 3.2. Activin A induced definitive endoderm differentiation from human ESCs.
(A) Schematic of the procedure employed to establish human definitive endoderm cells from H9
hESCs. This protocol employed using activin A (100 ng/ml) and Wnt3A (25 ng/mL) in serum free
differentiation medium (SFD) for 2 days, followed by 0.5% FBS and the PI3 kinase inhibitor
LY294002 for 2 additional days. (B) Expression of pluripotency markers in the definitive
endoderm cells (DE) relative to the ESCs. (C) Expression of definitive endoderm markers relative
to the ESCs. (D) Expression of gut transcription factors in definitive endoderm cells relative
ESCs, with the gut markers aligned according to their order of expression during embryonic
development. (E) Expression of adult ISC markers following endoderm differentiation. All
expression data are shown as the mean of triplicate experiments with the bars indicating the
standard error. All gene expression changes shown were statistically significant (p<0.001,
Student’s t test), with the exception of Id2, Msi1, and Ephb2, which were unchanged.
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Figure 3.3. Conditioned medium induced differentiation from definitive endoderm.
(A) Schematic of the culturing protocols employed to induce definitive endoderm to assume an
intestinal lineage. Mouse definitive endoderm cells were treated with fibroblast conditioned
medium (CM) or conditioned medium containing Wnt3A (CM+Wnt3A). (B) Expression of
intestinal transcription factors following exposure of endoderm cells to conditioned medium or
conditioned medium containing Wnt3A. (C) Expression of the posterior endoderm/gut markers,
Fabp2 and Cdx2, following exposure of endoderm cells to conditioned medium or conditioned
medium containing Wnt3A. (D) Expression of Muc2 in endoderm cells and endoderm cells
treated with CM plus Wnt3A. In this experiment, endoderm cells were treated with CM for 8 days
(instead of 4). In one culture, DAPM was included in the culture medium for the final 2 days. (E)
Expression of the ISC markers following exposure of endoderm cells to conditioned medium or
conditioned medium containing Wnt3A. (F) Expression of distal gut mesoderm markers
following exposure of endoderm cells to conditioned medium or conditioned medium containing
Wnt3A. All graphs show the mean of triplicate experiments (±standard error) with the expression
levels normalized to that found in definitive endoderm. The indicated changes were statistically
significant as determine by ANOVA (* p<0.01; ** p<0.001).
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Figure 3.4. Evidence for intestinal organoid formation in Wnt3A treated definitive endoderm.
(A) Representative phase contrast images of mESCs, definitive endoderm, and definitive
endoderm treated with Wnt3A conditioned medium (Intestinal lineage). Note the distinctive,
phase-dark periphery formed following treatment with Wnt3A. (B and C) Intestinal lineage cells
were fixed and sectioned for immunofluorescent staining. The left panel of B shows staining for
the general intestinal transcriptional regulator Id2. The corresponding DAPI-stained image is
shown to the right. The left panel of C shows the results of immunostaining for smooth muscle
actin. The corresponding DAPI-stained image is shown in the right panel.
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Figure 3.5. β-catenin, PCNA and Lgr5 expression in the putative intestinal organoids.
(A) β-catenin immunofluorescence of a sectioned organoid. The left panel shows the Cy3 staining
for β-catenin and the right top panel shows the β-catenin staining (red) merged with the DAPI
DNA staining (blue). (B) PCNA expression in two sectioned organoids. Immunostaining for
PCNA is shown in red and the DAPI DNA staining is blue. (C) Bright field images of two
representative organoids, with or without visible outcroppings. (D) Lgr5 immunofluorescence of
two sectioned organoids. The upper panel shows the Cy3 staining for Lgr5 and the lower panel
shows the Lgr5 staining (red) merged with PCNA staining (green). (E) Two crypt like regions
from organoids were stained for PCNA (FITC/green) and TFF3 (Cy3/red).
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Figure 3.6. Introduction of GFP-expressing definitive endoderm cells into the mouse colonic
mucosa. Mouse ESCs were treated to generate definitive endoderm (as in Fig. 1A) and introduced
transrectally into mice treated with DSS for 1 week. Twelve days after the cell introduction,
colonic tissue was removed and prepared for frozen sectioning. (A) Image of a cluster of GFPexpressing cells in the colon (blue is DAPI-stained DNA). (B) Sections of the mouse colon were
GFP-expressing cells were found associated into a crypt. (C) Serial sections of the mouse colon
with the left panel showing a section analyzed for GFP expression and the right panel showing
immunostaining for PCNA expression. (D) Serial sections of the mouse colon with the left panel
showing a section analyzed for GFP expression and the right panel showing Alcian blue staining
for mucopolysaccharide production.
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CHAPTER 4
DEVELOPMENT OF INTESTINAL ORGANOIDS AS TISSUE SURROGATES FOR THE
ANALYSIS OF STEM CELL DYNAMICS AND DIFFERTIATION

INTRODUCTION
The intestinal epithelium is a dynamic tissue in which stem cells positioned at the crypt
base provide progeny cells that differentiate and perform critical tissue functions such as the
secretion of mucous and anti-microbial defensins and the absorption of water and nutrients

11,12

.

Understanding the signaling pathways responsible for regulating the transition of stem cells from
their multi-potent state into defined differentiation pathways could provide important insight into
developing targeted treatments that maintain proper tissue structure and function.
Lineage tracing experiments have revealed the existence of multiple stem cell
populations within the intestinal and colonic crypts. Using this approach it was first shown that
Lgr5-expressing cells are positioned at the crypt base and that progeny of these cells go on to
become secretory and absorptive lineage cells

22,117

. Lgr5-expressing cells are characterized by

their columnar morphology and their relatively high rate of proliferation. They are located
between Paneth cells in the small intestine, with these latter cells playing an important role in
maintaining stem cell viability

118,119

. In addition to the rapidly cycling Lgr5 positive cells, a

slower cycling population of stem cells also exists. These cells are at position +4 relative to the
crypt base and were initially indentified as DNA label-retaining cells

120

. This population of cells

expresses Tert, Hopx and Lrig1, and lineage tracing shows that they also give rise to all the cell
types that constitute the intestinal epithelium

17,113–115

. Present data point to a potential hierarchal

relationship between the ISC populations with Tert/Hpox/Lrig1 +4 cells providing a stable source
of slow-dividing cells and the more rapidly cycling Lgr5 pool serving as the primary source of
cells under most circumstances17,21. Interestingly, inter-conversion between Lgr5 and +4 cells has
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been detected, suggesting that the tissue can withdraw cells from the stable +4 pool when needed,
and replenish the +4 pool as required

122

. Whether +4 cells and Lgr5-expressing cells are the

exclusive cell sources in the small intestine and colon is not entirely clear. Dclk1-expressing cells
have interesting properties in that they function as mature Tuft cells in the tissue, but they also
have seed the formation of glandular structures following transplantation20,76,124. Dclk1 may
therefore mark a differentiated cell type that can revert to a stem cell under some circumstances.
Interestingly, in situ hybridization experiments have indicated that Dclk1 cells may also express
the Lgr5 stem cell marker 78.
The signals that maintain the stem cell population within the intestines are provided by
cells at the base of the crypts. Myofibroblasts have long been recognized as important
components of the niche environment and provide an important source of Wnt to stimulate stem
cell proliferation. Epithelial cells and other cell types likewise express Wnt and other signals to
establish the niche. Present data support a model in which a range of positively and negatively
acting signals control ISC potency and the transition to mature cells as they move away from the
niche region

88,115

. Wnt proteins and associated agonists such as R-spondin promote division and

suppress differentiation at the base of the crypt, while Wnt inhibitors such as Dkk1 limit the
expanse of the Wnt signal

96,125

. Likewise, differentiation is signaled by BMP expressed higher in

the tissue, with this differentiation signal regulated by counteracting inhibitors such as Noggin
and Gremlin 126–128. Other important signals within the milieu of the tissue include EGF and EphB
which stimulate proliferation, and hedgehog ligands that promote differentiation

103,129–132

. Notch

signaling plays a critical role in regulating the dynamics of intestinal tissue. Evidence has been
obtained that Notch signaling through adjacent cell-cell interactions maintains both stem cell
potency and differentiation to an absorptive lineage (columnar epithelial cells and enterocytes) at
the expense of secretory cells (goblet, enteroendocrine and Paneth cells) 52. Key to this activity is
the Notch target gene Hes1. Hes1 is a basic-helix-loop-helix (bHLH) protein that suppresses
Atoh1 expression and activity

133

. Atoh1 is likewise a bHLH protein that regulates gene
41

transcription and stimulates the differentiation of secretory cells in the small and large intestine
134

. Studying the impact of Notch signaling on intestinal tissue has been facilitated by the

availability of specific γ-secretase inhibitors. These inhibitors prevent cleavage of the Notch
receptor following ligand engagement and thereby the generation of the Notch intercellular
domain (NICD) proteolytic fragment responsible for altering expression of target genes.
Treatment of mice with γ-secretase inhibitors promotes the formation of goblet and other
secretory cells

135,136

. This potent differentiation function can halt the growth of intestinal tumors

in ApcMin/+ mice by inducing tumor cells to terminally differentiate into goblet cells. In normal
mucosa, γ-secretase inhibitors can increase goblet cell differentiation and mucous production to
protect intestinal tissue from DSS-induced inflammation. These findings exemplify how
understanding the differentiation pathways in the mucosa can be utilized for developing novel
approaches for treating disease.
Our understanding of the signaling pathways involved in regulating cell dynamics in the
intestines comes largely from studying mouse models and transformed cell lines. Recently,
technology has been developed that enable the growth of intestinal organoids, either from isolated
ISCs or following differentiation of ESCs

8,9

. These organoids possess both stem cell and

differentiated cell components that are organized much like they are in the intact mucosa. These
organoids open up the opportunity for the rapid analysis of biological agents and small molecules
for their ability to alter the growth and differentiation of intestinal cells, which in turn could result
in the uncovering of new signaling mechanisms and novel pharmacological targets. ESC-derived
organoids have some potential advantages, including the ability to generate large numbers of
organoids from ESCs of wide range of genetic backgrounds. In this report we characterize the cell
types that constitute IOs obtained from mouse ESCs following differentiation conditions
described by ourselves and others. We find that these organoids are enriched in ISCs and that they
include both Tert+ and Lgr5+ stem cells. Although Atoh1 and Hes1 expressing cells are present in
these populations, fully differentiated cells constitute only a few percent of the organoid. Long42

term culturing of the organoids showed that cell differentiation was sensitive to culture
conditions, whereas the stem cell populations remained relatively stable. Finally, our data show
that organoids generated from ApcMin/+ mice have a reduced capacity to produce Atoh1-expressing
cells, similar to what is observed in intestinal tissue. From these data we propose that IOs are
useful for modeling ISCs and early stages of their differentiation. They may be particularly useful
for developing approaches that suppress the progression of mutated intestinal cells to malignancy.
RESULTS
Cell types in ESC-derived definitive endoderm and intestinal organoids
Conditions have been described for generating IOs from human or mouse ESCs and
IPSCs

8–10

. These approaches entail an initial enrichment for definitive endoderm (DE), using

activin A to simulate embryonic nodal signaling, followed by a posteriorization of the resulting
endoderm by treatment with Wnt ligand. As previously reported, RNA analysis from organoids
generated in this manner express the ISC genes Lgr5 and Tert, as well as differentiation regulators
and terminal differentiation markers. Figure 4.1A shows a schematic of the differentiation
procedure, with Wnt3a conditioned medium used to induce intestinal differentiation of DE, as
indicated by increased expression of the mucin gene Muc2 and the intestinal fatty acid binding
protein, Fabp2 (Figure 4.1B). Under this culture condition, expression of the stem cell markers
Lgr5 and Tert and the differentiation regulators Atoh1 and Hes1 were relatively unchanged in the
endoderm to organoid transition (Figure 4.1B).
To better understand the composition of the DE and IOs, cells were dispersed, sorted by
the flow cytometry and assayed individually for gene expression. As a comparison, cells were
stripped from the colonic mucosa and assayed in parallel. We have previously reported that this
approach generates an accurate representation of gene expression profiles within the cell
population, based on reconstruction of bulk expression levels. As shown in Figure 4.1C, cells in
the DE and organoids were much more likely to express a stem cell marker, relative to those
obtained from the colon (e.g., Lgr5, Tert and Msi1). Conversely, cells stripped from the colon
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more frequently expressed genes associated with secretory or absorptive cell lineages, Muc2 and
Fabp2, respectively. In general, these data indicate that the 10 day old organoids are enriched in
stem cells and cells that inhabit the crypt base. Although organoids do express Muc2 and Fabp2
mRNA, we estimate they these cells constitute less than one percent of the total population of the
organoids maintained under these growth conditions.
Cluster analysis of stem cell markers
To better characterize the cells in the organoids expressing stem cell markers, individual
RNA expression profiles were examined. As shown in Figure 4.2, Msi1 was broadly expressed in
both the DE and the organoids. The expression of Tert and Lgr5 was more limited, consistent with
these mRNAs serving as more selective markers of ISCs. Importantly, the Lgr5 and Tert
expressing cells resolved into two distinct subpopulations, consistent with the two ISC
populations observed in intestinal tissue

17,21,77

. Dclk1 resolved into an independent cluster, but

was also found to be co-expressed with Lgr5. The co-expression of Dclk1 with Lgr5 has been
reported in intestinal mucosa

77

. This latter finding suggests that there may be distinct types of

Dclk1 expressing cells in the DE and organoids.
Structural organization of intestinal organoids
We and others have reported that intestinal organoids assemble into structures that are
organized in a manner reminiscent of the intestinal mucosa. Figure 4.3 shows the
immunofluorescent staining of DE and organoids for active β-catenin, Atoh1 and Dclk1. Colon
tissue was stained as a control. Both the DE and the IOs stained for active β-catenin. In the
smaller DE, staining was relatively uniform throughout the embryoid bodies. Active β-catenin in
the organoids was somewhat more structured, with staining most intense at the periphery or
within small invaginations. These regions of the organoid resemble the crypt base, which likewise
stains intensely for active β-catenin. Also shown in Figure 4.3 is the Atoh1 staining of the
intestine, DE and organoids. Atoh1 staining of the tissue reveals Atoh1 expressing cells scattered
throughout the epithelium typically positioned above the crypt base where it regulates the
44

commitment to a secretory cell lineage

134

. Atoh1 cells were found to be rare in the DE, but more

frequently apparent in the organoids (Figure 4.3). In the organoids, Atoh1 expressing cells were
positioned towards the center of the bodies, in contrast to the cells expressing active β-catenin
usually at the periphery.
DE and IOs were examined for the positioning of Dclk1 expressing cells. In the colonic
epithelium, Dclk1-expressing cells are found at variable positions with several present in each
crypt (Figure 4.3). These cells can usually be identified as Tuft cells, which are cells of the
secretory lineage

76,124

. Analysis of Dclk1-expressing cells in the DE shows that these cells were

positioned almost exclusively at the surface of the embryoid bodies (Figure 4.3). Although
Dcamk1-expressing cells were most abundant in the DE, they could also be detected in the
organoids where they were likewise positioned at the surface.
Effect of differentiation conditions on organoid cell composition
The IOs at day 10 showed expression of terminal differentiation markers Muc2 and
Fabp2 in the bulk RNA, but no cells were detected in the single cell analysis. These data
indicated that the number of mature cells in the population was relatively small. To determine
whether the number of mature cells increased with longer periods of time, culture conditions were
extended to days 16 and 27. In addition, we compared two differentiation protocols

8,9

(Figure

4.4A). DE was generated as usual for both protocols. In protocol 1, posteriorization of the DE
was achieved using medium conditioned by a mouse fibroblast line expressing a Wnt3a transgene
(providing the requisite Wnt and FGF signals; Figure 4.4A). In protocol 2, DE was treated with
recombinant FGF and Wnt3a for 4 days, followed by culturing in medium used to maintain IOs
(which includes R-spondin, EGF and Noggin; Figure 4.4A). Single cells were isolated on days 16
and 27 of these protocols and analyzed for mRNA expression as in Figure 4.1C. As shown in
Figures 4.4B and 4.4C, both differentiation procedures lead to a drop in the number of cells
expressing Msi1. In addition, Muc2 and Fabp2 expressing cells were now detected, although
these cells still constituted only a small percent of the total.
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To determine how the stem cells were affected by the longer-term culturing in the two
media, gene expression profiles were used to cluster the cells expressing stem cell markers. In
general, the number of cells expressing an ISC marker did not change dramatically, regardless of
time or culture conditions (Figure 4.5) , indicating that the organoids were still populated mostly
by crypt-like cells. Discreet populations of Lgr5 and Tert positive cells were still apparent at days
16 and 27. One notable shift in the clusters was a trend to resolution by day 27, at which time
Tert-expressing cells under both conditions were largely Msi1-resolved almost entirely from the
Lgr5 subpopulation by day 27. How these changes effect stem cell potency is however not known
negative (whereas many Lgr5 positive cells continued to co-express Msi1). In addition, Dclk1
expressing cells, but suggest that the stem cells in the organoids mature over time.
The differentiation regulators Hes1 and Atoh1 control the alternative differentiation
pathways to secretory or absorptive cell 52,134. Both Hes1 and Atoh1 were variably expressed with
time under both culturing conditions. Notably, however, the expression of these two genes was
inversely correlated; an increase in one was accompanied by a decrease in the other (Figure 4.4BC). This finding is consistent with the repressive activity of Hes1 on Atoh1 expression

137

. The

apparent oscillation in Hes1 and Atoh1 expression may be related to the presence of regulatory
feedback pathways in the organoids.
Sensitivity of organoids to long term culture conditions
To determine if the culture conditions could affect differentiation trajectory of the
organoids, we maintained organoids in Wnt conditioned medium for 47 days, at which time RNA
was isolated and analyzed for the expression of the secretory cell marker Muc2 and the absorptive
cell marker Fabp2 (Figure 4.6A). Interestingly, organoids maintained in IOM medium expressed
higher levels of Muc2 whereas those in CM Wnt expressed more Fabp2. In addition, Alcian blue
staining of the IOM organoids indicated mucin production (Figure 4.6B), whereas CM Wnt
cultured organoids were negative for Alcian blue staining (not shown). These data demonstrate
that the cellular differentiation fate within the organoids is sensitive to the growth medium
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conditions, indicating that the organoids can be employed for studying agents that impact
differentiation.
Effect of genetic background and intestinal organoid characteristics
To determine whether the intestinal organoid system is a suitable model for studying
initiated intestinal mucosa, we generated organoids from ESCs from the cancer-prone ApcMin/+
mouse strain. Although tumor formation in these mice requires loss of the wild type Apc allele,
heterozygous tissue shows a number of phenotypic changes, including a reduction in Atoh1
expression and a decrease in the proportion of secretory cells within the tissue. We subjected to
ApcMin/+ ESCs to the differentiation protocol using protocol 2 (Figure 4.4A), and determined the
impact of Apc heterozygosity on mRNA expression in the organoids at days 10, 16 and 27. As
shown in Figure 7A, the most dramatic change observed was a reduction of Atoh1 mRNA
expression in the heterozygote organoids. Single cell analysis showed that the reduced level of
Atoh1 mRNA expression corresponded to a reduced number of Atoh1-expressing cells (Figure
4.8A). The reduction in Atoh1 expression was in contrast to the number of Hes1-expressing cells,
which was largely unchanged (Figure 4.8A). Figure 8B shows representative images of Atoh1
and β-catenin staining of wild type and ApcMin/+ organoids; the number of Atoh1 expression cells
was lower in the ApcMin/+ organoids, whereas β-catenin staining which was similar. Consistent
with our findings, the number of cells expressing Atoh1 has been reported to be reduced in the
intestines of Apc heterozygote mutants.
Examination of stem cell marker expression showed that, like the wild type organoids,
cells in the ApcMin/+ organoids can be resolved into distinct Lgr5 and Tert expressing populations.
The number of Lgr5-expressing cells was higher in the ApcMin/+ organoids relative to wild type
organoids cultured under the same conditions (compare to Figure 4.5), but this difference was not
statistically significant. The expression Lgr5 and Tert in the bulk mRNA was similar for both wild
type and ApcMin/+ organoids (Figure 4.7A). The Apc mutation does not appear to disturb the
resolution of the stem cells into their distinct populations, and they appear in the organoids in
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roughly the same numbers.
DISCUSSION
As our understanding of tissue stem cell niches improves, increasingly sophisticated cell
culture systems are being developed that can maintain adult stem cells in vitro. This is true for
adult stem cells derived from the intestinal. Methods have also been described for deriving cells
with ISC properties from mouse or human ESCs and IPSCs

8–10

. These protocols involve the

differentiation of cells to definitive endoderm, and then treating with Wnt and FGF source. Under
a number of different described culture conditions, the isolated stem cells undergo their normal
differentiation program and form organoids that maintain some of the structural characteristics of
intestinal tissue. Whether prepared from adult ISCs or ESCs, IOs can be maintained in culture for
prolonged periods of time, a process facilitated by the availability of recombinant and purified
developmental signaling proteins, such as Wnt and R-spondin, which supports the survival and
expansion of the ISCs within the organoids

96

. IOs may provide a source of ISCs to repair

intestinal tissue damaged by chronic inflammation, infection or radiation.
In addition for use in tissue repair, organoids may also be useful as tissue surrogates for
studying aspects of intestinal cell proliferation and survival and may also generate insight into
pathologies associated with dysfunction of the intestinal epithelium. It has recently been reported
that intestinal organoids developed from human stem cells supported the replication of rotavirus
isolates directly from stool samples, demonstrating their potential usefulness for studying
gastrointestinal viruses

138

. The application of organoids from the intestine could even be useful

for the screening of small molecule libraries or siRNA/shRNA reagents to gain novel insight into
intestinal cell biology and the signaling pathways that control their growth and differentiation.
However, applying IOs as tissue surrogates requires a detailed knowledge of their composition
under different culture conditions. This is particularly true for ESC-derived organoids; although
the ability to expand and genetically manipulate ESCs provides advantages over tissue-isolated
stem cells, it is not entirely clear how their composition related to the composition of intestinal
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mucosa. For this reason we performed a detailed characterization IOs from mouse ESCs under a
number of different growth conditions. We were particularly interested in determining which
culture conditions were well-suited for analyzing ISCs and their commitment to an absorptive or
secretory lineage. The data from our analysis is consistent with IOs under these conditions being
enriched for ISCs (relative to the intestinal mucosa). Our data indicate that Lgr5 or Tert
expressing cells constitute a few percent of the cells in the colonic epithelium. In contrast, twenty
to thirty percent of the cells in our IOs express Lgr5 or Tert, two of the more discriminating ISC
markers. Importantly, the Lgr5 and Tert expressing cells could be resolved into two distinct
populations, similar to the intestinal mucosa

21,77,78

. The enrichment in ISCs is likely due to the

relatively high levels of Wnt, R-spondin and other stem cell niche factors present in the medium.
In addition to the stem cells, the organoids also include cells that express Atoh1, which regulates
secretory cell differentiation. In the intestinal mucosa, Atoh1 expressing cells are positioned
approximately half way up the crypt. In the organoids generated here, they usually are positioned
at the center of the organoids. These data suggest the organoids generated in our studies resemble
the crypt extending up to the Atoh1 expressing cells, and probably not much further given the low
numbers of Muc2 and Fabp2 expressing cells identified. This model therefore is suitable for
studying ISCs and early events in the differentiation process.
Intestinal tissue at risk for cancer development, whether it is in the small intestine or
colon, is frequently preceded by an expansion of the proliferative zone of the crypt with
alterations in the execution of differentiation programs. ISC positioning within the crypts may
also be affected. In the majority of colon cancers, a truncating mutation in the Apc gene is among
the earliest genetic change. Although mutation in one of the Apc genes does not result in the
formation of a neoplasm, intestinal cells change is a number of ways. One change that may be
particularly amenable for study in the organoid system is the reduced Atoh1 expression.
Specifically, Apc+/- have a reduced frequency of Atoh1-expressing cells in the small intestinal
crypts, and as a result show a lower level expression of genes associated with a secretory cell
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phenotype. This phenotype is reproduced in the IO system, as Apc+/- organoids have a reduced
number of Atoh1 expressing cells. The mechanism linking Apc heterozygosity and Atoh1
expression is not known, but could involve changes in Wnt or Notch signaling. The reduced
expression of Atoh1 could serve to promote cancer development by suppressing an important
growth-regulating differentiation pathway, or by rendering the tissue more susceptible to
inflammation due to a reduced production of mucus and other anti-microbial defenses. It has been
reported that enhancement of Atoh1 expression and secretory cell differentiation with Notch
pathway suppressing γ-secretase inhibitors can reduce inflammation and intestinal cancer
development in the mouse. The organoid system appears to be well-suited for studying this
differentiation event in more detail, and potentially for identifying novel compounds that can
promote Atoh1 expression. Other phenotypes associated with Apc heterozygosity includes mitotic
spindle defects and shifts in metabolism. Although we have not examined these other changes in
detail, it is possible that the organoid system could be useful for studying these alterations as well.
One advantage of the organoid system as a tissue surrogate is that organoids can be
developed from both human and mouse stem cells. As discussed above, IOs have been generated
from human ESCs, IPSCs and adult stem cells. Although the human organoids will be invaluable
for studying individual risk factors for cancer and IBD, we have chosen to focus on the mouse
system for a number of reasons. One important advantage of the mouse system is the ability to
generate IOs with precisely defined genetic defects so that mutated and wild-type organoids can
be directly compared. This should give us the opportunity to determine how signaling and gene
expression defects in the mutant organoids might be corrected. In the case of Atoh1 expression
and secretory cell differentiation, the identification of nutritional agents and/or small molecules
that can selectively enhance Atoh1 in the Apc heterozygote organoids could have
chemopreventive value. Any agents identified in the mouse organoid system could then be
directly tested in the mouse for cancer prevention properties and screened for general
effectiveness in a panel of human IOs (derived for example from FAP patients). Although our
50

work here is focused on Apc mutant organoids, other cancer-related mutations could be similarly
analyzed.
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Figure 4.1. A) Flow diagram of differentiation procedure. Mouse ESCs were detached from
fibroblasts on day 0 and grown as embryoid bodies in the presence of activin A to day 6. On day
6, the resulting definitive endoderm was transferred to medium containing Wnt3a and allowed to
further progress until day 10. B) Gene expression analysis at days 6 and 10. RNA was isolated
from definitive endoderm (DE) or intestinal organoid cultures (IO) and analyzed for the
expression of Lgr5, Tert, Atoh1, Hes1, Muc2 and Fabp2 by quantitative PCR. Values shown are
relative to the expression in definitive endoderm. Expression of the differentiation markers Fabp2
and Muc2 was significantly increased in the organoids (p < 0.01, Students t test). C) Single cell
analysis of RNA expression. Cells from definitive endoderm and intestinal organoids were
dispersed into single cells and sorted by flow cytometry. Cells from the colonic epithelium were
likewise dispersed into single cells and sorted following EDTA stripping. Approximately 96 cells
were analyzed in each sample. Cells in intestinal organoids were found to express Dclk1, Lgr5,
Tert, Msi1 and Hes1 at a significantly greater frequency than the cells in the organoids, whereas
the expression of Atoh1, Muc2 and Fabp2 was less frequent (p < 0.005; Fisher’s exact test).
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Figure 4.2. Cell clustering based on stem cell marker expression.
Hierarchical clustering of cell types was performed using JMP analysis software. Single-cell
expression values (dCT*) range from blue (not detected) to red (highly expressed). Of the total
number of cells expressing Lgr5 and Tert in the definitive endoderm, only two co-expressed these
markers (p = 0.011, Chi-square test). For the intestinal organoids, none of the cells co-expressed
Tert and Lgr5 (p = 0.017).
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Figure 4.3. Expression of β-catenin, Atoh1 and Dclk1 in colonic mucosa, definitive endoderm
and intestinal organoids.
Colon tissue, DE and organoids were fixed, sectioned and immunostained for the indicated
protein markers using Cy3 β-catenin and Dclk1) or FITC (Atoh1) conjugated secondary
antibodies. DAPI staining was performed to reveal the presence of the nuclei.
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Figure 4.4. Effect of differentiation conditions on organoid cell composition.
A) Protocols used to generate intestinal organoids. In both protocols, activin A was employed to
enrich cultures in definitive endoderm. In protocol 1, cells were switched to medium conditioned
with Wnt3a-expressing mouse L cells (Wnt CM). In protocol 2, cells were treated with
recombinant Wnt3a and FGF until day 10, and then switched to intestinal organoid medium
(IOM) containing R-spondin (Rs), EGF and noggin (Ngn) for the remaining time period.
Individual cells were isolated on days 16 and 27 and processed for RNA analysis. B and C) Single
cell transcript analysis of organoids generated by protocols 1 and 2. Organoids were dispersed
and sorted into individual cells by flow cytometry. Each cell was examined for the transcripts
shown by RT-PCR using the Taqman assay. The percentage of cells expressing the transcripts
under the different conditions is shown. Data from epithelial cells stripped from the colon are
shown for comparison. DE is the definitive endoderm, IO_D16 and IO_D27 are cells from day 16
and day 27 organoids, respectively. Gene expression changes of interest include a significant drop
in Msi1 expression at day 27, relative to definitive endoderm, under both medium conditions (p <
0.001, Fisher’s exact test). However, the number of Msi1 expressing cells still remained
significantly higher in the organoids relative to the colon (p < 0.005). There were more Lgr5 and
Tert expressing cells in the organoids relative to the colon (p < 0.05), although this difference was
not significant for Lgr5 in Wnt CM medium conditions. The number of cells expressing the
terminal differentiation markers Muc2 and Fabp2 remained significantly lower in the organoids
relative to the colon (p < 0.0001 and p < 0.05), respectively.
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Figure 4.5. Cell clustering based on stem cell marker expression profiles of day 16 and day 27
intestinal organoids generated by protocols 1 and 2 (Figure 4A).
Hierarchical clustering of cell types was performed using JMP analysis software. Single-cell
expression values (dCT*) range from blue (not detected) to red (highly expressed). The resolution
of Lgr5 and Tert expressing cells into two distinct populations continued to be apparent for the
Wnt CM and IOM conditions (p < 0.05 and p < 0.001, respectively). A trend to the resolution of
Msi1 and Tert was also observed, as was a statistically significant separation of Dclk1 and Lgr5
expressing cells in IOM medium at day 27 (p < 0.05).
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Figure 4.6. Sensitivity of organoids to long term culture conditions
A) Influence of culture conditions on long-term organoid differentiation. Bulk RNA was prepared
from organoids cultured under protocol 1 or protocol 2 conditions until days 16, 27 or 46, and
then analyzed for Muc 2 or Fabp2 by RT-PCR. At day 46, the expression of Muc2 in the IOM
cultured organoids was significantly higher than that found in Wnt CM organoids (p < 0.001;
ANOVA). At 27 and 46 days, the Wnt CM organoids expressed more Fabp2 (p < 0.001). B) H&E
and Alcian blue staining of organoids from protocol 2/IOM conditions.
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Figure 4.7. Comparison of intestinal organoids generated from wild-type or ApcMin/+ intestinal
organoids. Organoids were generated using protocol 2 (with maintenance in IOM medium). Bulk
RNA and single cell transcript profiling was then performed. A) The RNA expression levels from
wild type (WT) and ApcMin/+ (MIN) organoids, analyzed on the indicated days (in triplicate).
Values shown are relative to expression levels in wild type definitive endoderm. The wild type
organoids expressed significantly higher levels of Dclk1 and Atoh1, relative to the ApcMin/+
organoids (p < 0.005; ANOVA). B) Cell clustering by stem cell marker expression. Individualized
cells from the ApcMin/+ organoids were analyzed for stem cell marker expression with the data
clustered using JMP software. As with the wild type organoids, Tert and Lgr5 expressing cells
existed as discreet subpopulations (p < 0.05).
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Figure 4.8. Effect of genetic background and intestinal organoid characteristics
A) Frequency of Atoh1-expressing cells in wild type and ApcMin/+ organoids. Organoids from wild
type and ApcMin/+ ESCs were generated using protocol 2, and at day 16 cells were dispsersed for
single cell analysis. The number of Atoh1 and Hes1 expressing cells in the culture were
enumerated. There are significantly fewer Atoh1 expressing cells in the ApcMin/+ intestinal
organoids relative to the wild type organoids (p < 0.001; Fisher’s exact test). B) ApcMin/+ and wild
type
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CHAPTER 5
CONCLUSIONS
The mammalian intestine is lined with a single layer of epithelial cells with a rapid cell
turnover rate. Renewal of the epithelium depends on the ISCs residing in the base of crypts. The
ISCs give rise to the transit-amplification cells, then migrate up to terminally differentiate into the
secretory cells including goblet cells and enteroendocrine cells or absorptive enterocytes. This
high cell turnover of intestine epithelium makes it a very attractive system for the study of
developmental biology and regenerative biology.
Recently, we and others have focused on developing multi-cellular structures called
intestinal organoids. These IOs, derived from ESCs, induced pluripotent stem cells and adult ISCs
that can be cultured and grown quickly in a defined medium system and resemble in vivo
intestinal crypts, both in structure and developmental processes. In the studies described within
this thesis, I assessed the potential of differentiating ESCs to commit to an intestinal lineage using
a two-step differentiation protocol. In the first step of this procedure, the definitive endoderm was
generated from ESCs under the induction of Activin A. By the end of this step, the definitive
endodeerm cells expressed not only definitive endoderm markers as expected, but also the ISC
marker Lgr5 expression. The potential of definitive endoderm cells for repairing damaged
intestinal tissue was then evaluated by transferring definitive endoderm cells into DSS-damaged
colon of mice. The definitive endoderm cells could engraft into damaged colonic tissue,
proliferate to form crypt-like structures and differentiate to intestinal epithelium. In the second
step of our protocol, the definitive endoderm was treated with fibroblast-conditioned medium
containing Wnt3a to generate intestinal organoids. By the end of this step, the definitive
endoderm cells form crypt-like structures and activate expression of differentiation markers
Fabp2, Muc2 and Tff3. Interestingly, enriched Lgr5 expressing cells were clustered in the
intestinal organoids indicating the generation of a niche-like region of the organoid.
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Further characterization of the cell types that constitute intestinal orgaoids was performed
using the two-step protocol under different culture conditions with different sources of Wnt and
FGF. Single cell RNA analysis from organoids generated under these culture conditions showed
that both Lgr5 and Tert expressing cells were found in the intestinal organoids, but resolved into
two distinct subpopulations; consistent with the two ISC populations observed in intestinal tissue.
Distinct types of Dclk1 expressing cells were also found in the DE and organoids; one resolved
into a distinct group, and the other co-expressed Lgr5. Furthermore, cells expressing the
differentiation markers Atoh1 and Hes1 were present in the organoids, but cells expressing
mature intestinal cell markers Fabp2 and Muc2 were rare, indicating that the organoids were
largely crypt-like. Finally, organoids generated from ESCs from the cancer-prone ApcMin/+ mouse
strain were utilized to determine whether the IOs system is a suitable model for studying initiated
intestinal mucosa. Bulk RNA analysis, single cell analysis, and immunostaining for Atoh1
showed that organoids generated from ApcMin/+ mice have a reduced capacity to produce Atoh1expressing cells compared with organoids from normal ESCs; consistent with what was observed
in intestinal tissue. This finding indicates that at least one of the phenotypes associated with this
early cancer mutation is reproduced in the organoids.
Future directions
The gene expression profiles of IOs provide the evidence that the IOs from ESCs closely
resemble cells positioned at the base of the crypt of the ileum and colon. The ease of
manipulation, relatively fast growth rate, and cost savings of IOs make it possible to use our twostep protocol to generate IOs for a range of applications including high-throughput screening for
the study of developmental biology of intestine, regenerative medicine, and drug discovery. In
particular, they may be useful for studying early colorectal cancer progression, cell signaling
associated with inflammatory diseases, and developing novel therapies or preventive agents for
diseases. The work described in this thesis focused on the development and characterization of
the mouse IOs system. Given this focus on technology development, it outlines how these
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organoids could be used to address important issues in colorectal cancer research.
According to the American Cancer Society, colorectal cancer (CRC) is the third most
common cause of cancer related deaths in the United States. About 50-85 percent of colorectal
cancer begins as precancerous polyps, then progress through a series of morphological stages,
which associated with some gene changes. Mutations on genes involved in colorectal cancer
progression include APC/β-catenin, K-RAS, DCC, SMAD4, SMAD2, p53, and other changes
that drive normal epithelium to metastasis 139. Researchers focus on the study of gene function in
this multistage progression using the transgenic approaches, normally through transgenic mouse
models. However, generating and maintaining such animal models is laborious, costly, and timeconsuming. An advantage of the organoid system is that organoids can be genetically manipulated
to recapitulate different stages of cancer progression. For example, mutation in one of the APC
loci is a very early step in colon cancer development, followed by the loss of the second loci.
However, the mechanism by which the second locus is lost is unclear. It has been proposed that
truncation in the APC gene will interfere with normal mitotic processes due to its dominant
negative impact on microtubule 140,141. The effect of the truncating APC mutation on microtubules
is independent of its role in β-catenin regulation. The defects in microtubule regulation at
centrosomes and kinetochores lead to spindle abnormality, subsequently initiating chromosome
instability (CIN) in a dominant manner, and ultimately initial colorectal cancer progression

142

.

SMC1L1, CSPG6, STAG3 are identified to be homologs of yeast genes that regulates sister
chromatid cohesion. Somatic mutations in these genes result defective sister chromatid cohesion,
thus cause CIN in human colorectal cancers

143

. Gene knockdown of these genes can be

performed by transfecting siRNAs into normal or ApcMin/+ ESC-derived organoids. The
genetically organoids could then be screened to determine the extent to which loss of
heterozygosity (LOH) is affected. This approach could facilitate the rapid analysis of how a range
of mitotic regulating factors impact the rate of LOH in cells with a truncated APC.
Earlier studies have suggested that reactive oxygen species (ROS) may play important
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roles in initiation, promotion and progression in the multistage carcinogenesis model. Excessive
generation of ROS breaks balance between ROS and antioxidants in cells leads to oxidative
stress, which have been proved to associate with CIN, resulting LOH and carcinogenesis. To
maintain the rapid turnover of intestine epithelium, epithelium cells have high metabolic rate,
which may produces ROS byproducts and potentially increase oxidative damage of lipids,
proteins, carbohydrates and nucleid acids. Previous data have indicated that proliferating cells in
the lower crypt are sensitive towards hydrogen peroxide damage than the upper differentiated
cells in colon. The self-renewal and differentiation of ISCs and transient amplification cells
require redox environment to prevent DNA damage elicited by chronic oxidative stress.
Organoids generated in our study represent the lower section of crypts covering stem cell zone,
transient amplification zone, and progenitors for differentiated cells and could be used as
toxicological model to screen for agents that promote or prevent LOH induced by ROS.
The IOs generated from our two-step protocol contain fast-cycling Lgr5-expressing stem
cells and slow-cycling Tert-expressing stem cells, as well as transit-amplifying cells. In fact, these
cells are highly represented in the organoids generated under our procedures. It is likely that the
stem cells are the primary targets of carcinogens, since mutations in these cell populations could
be propagated through multiple cell generations, during which time additional genetic mutations
could be incurred that ultimately lead to cancer development. However, almost nothing is known
about the ability of the different stem cell populations to respond to DNA damaging agents and to
repair their DNA. Endogenous and exogenous agents trigger DNA damage through the chemical
events including hydrolysis, exposure to reactive oxygen substances, and other reactive
metabolites 144. Carcinogens dimethylhydrazine (DMH) and azoxymethane (AOM) are alkylating
agents, which are known to produce DNA adducts, such as O6-methylguanine (O6-MeG) and N7methylguanine, and an abnormal methylation pattern145,146.

During DNA replication,

methyldiazonium ion alkylates DNA bases with formation of DNA adduct O6-MeG to induce Gto-A transitions to promote colorectal cancinogenesis147. In the colonic crypt, DNA damage
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induced by AOM is greater in proliferating cells than in the mature cells and apoptosis is also
primarily targeted to the cells in base of the crypt 147.
Variety of DNA-damaging agents including ionizing radiation, UV and natural or man-made
genotoxic chemicals (eg. methylmethane sulfonate) can be used to induce DNA damages in
organoids. Tert-positive and Lgr5-positive cells could be then sorted by fluorescence-activated
cell sorting after the treatment. Relative number of Lgr5 positive and Tert positive cells, and the
sensitivity of these two distinct groups of ISCs to carcinogens will be evaluated. Information
about the level of DNA damage, tumour-specific DNA repair responses (eg. ATM activated p53),
and arrest cell cycle (G1/S, G2/M) in the Lgr5 positive and Tert positive cells may indicate an
approach to evaluating cancer risk based on the relative number of Lgr5 or Tert cells found in the
colon. For this reason, improving carcinogen resistance through repair or targeted apoptosis has
shown promise for colon cancer prevention.
To establish efficient IOs for colon cancer research in 3D cell culture, first issue to
address is how to establish a defined long-term culture system. It is important to demonstrate the
cells in the IOs have biological activity and phenotype as cells in the intact tissue. We have
produced IOs derived from wild type and ApcMin/+ ESCs using the growth medium containing Rspondin1, EGF, and Noggin. We characterized the cell composition of these IOs using single cell
analysis. To make the system more convincing, the architecture of IOs can be determined using
IHC and IF. Furthermore, to generate IOs with cancer genetic background, the culture system
may need to be modified; for example, the APC-deficient orgaoinds may prefer different
conditions with different growth factors and agents, especially medium without Noggin and Rspondin 1. APC-deficient orgaoinds can be maintained in the defined medium for long time
period and resemble closely to the epithelium from APC-deficient animals. After the suitable
culture conditions are determined, the ApcMin/+ organoids can be injected into nude mice to
confirm the formation of intestinal cancer-like adenomas or tumors. This will prove the function
of the IOs with genetic deficient. Further attempt to establish the IOs surrogates can be carried by
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gene knockouts and knock-ins with normal or ApcMin/+ ESC-derived organoids. This approach can
generate more IOs models in vitro for intestine disorder researches.
Although only a few potential applications of intestinal organoids for studying colon
cancer development are discussed, other applications can also be envisioned. The contribution of
the work described in this thesis is the development and in-depth thorough characterization of the
mouse IO system. Genetically-define mouse IOs are anticipated to provide researchers with an
efficient and well-defined system that can be used in conjunction with mouse models, human IOs
and other traditional systems to improve our understanding, treatment and prevention of diseases
of the intestine and colon.
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Table 3: Establish IOs for colon cancer research.
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APPENDIX I
ENANTIOCONVERGENT PRODUCTION OF (R)-1-PHENYL-1,2-ETHANEDIOL
FROM STYRENE OXIDE BY COMBINING THE Solanum tuberosum AND AN
EVOLVED Agrobacterium radiobacter AD1 EPOXIDE HYDROLASES

Abstract
Soluble epoxide hydrolase (EH) from the potato Solanum tuberosum and an evolved EH of the
bacterium
Agrobacterium radiobacter AD1, EchA-I219F, were purified for the enantioconvergent
hydrolysis of racemic styrene oxide into the single product (R)-1-phenyl-1,2-ethanediol, which is
an important intermediate for pharmaceuticals. EchA-I219F has enhanced enantioselectivity
(enantiomeric ratio of 91 based on products) for converting (R)-styrene oxide to (R)-1-phenyl1,2-ethanediol (2.0 ± 0.2 mmol/min/mg), and the potato EH converts (S)-styrene oxide primarily
to the same enantiomer, (R)-1-phenyl-1,2-ethanediol (221 mmol/min/mg), with an enantiomeric
ratio of 40 ± 17 (based on substrates). By mixing these two purified enzymes, inexpensive
racemic styrene oxide (5 mM) was converted at 100% yield to 98% enantiomeric excess (R)-1phenyl-1,2-ethanediol at 4.7 ± 0.7 mmol/min/mg. Hence, at least 99% of substrate is converted
into a single stereospecific product at a rapid rate.
Keywords: epoxide hydrolase; styrene oxide; phenyl-1,2-ethanediol; enantioconvergent
INTRODUCTION
Interest in using epoxide hydrolases (EHs, EC 3.3.2.3), enzymes that hydrolyze epoxides
to diols for synthesis of enantio-pure compounds (Manoj et al., 2001), is increasing for the
production of pharmaceuticals (Monterde et al., 2004; Schoemaker et al., 2003). For example, the
pharmaceutical intermediate, enantio-pure (R)- or (S)-mandelic acid, is used in the synthesis of blactam antibiotics and analytical reagents (Groger, 2001), and (R)-mandelic acid may be made
from (R)-1-phenyl-1,2-ethanediol (Drummond et al., 1990; Lindstad et al., 1998). EchA is an EH
80

(294 aa) (Rui et al., 2004) from the gramnegative strain Agrobacterium radiobacter AD1 that
allows the cell to utilize epichlorohydrin as a sole carbon source (Jacobs et al., 1991). A variant of
EchA was generated by saturation mutagenesis with one amino acid change I219F (EchA-I219F)
(Rui et al., 2004) that hydrolyzes racemic styrene oxide twofold faster than wild-type EchA while
having enhanced enantioselectivity for producing (R)-1-phenyl-1,2-ethanediol (enantiomeric ratio
of 91 vs. 17 based on product) (Rui et al., 2005). Plant soluble EHs play a central role in
producing cutin, aromatics, and anti-fungal compounds (Morisseau et al., 2000); they have been
isolated from at least eight plants to date (Elfstrom andWidersten, 2005; Morisseau et al., 2000).
cDNA encoding a soluble EH (322 aa) from potato (S. tuberosum, StEH) was cloned and
characterized (Morisseau et al., 2000; Stapleton et al., 1994). The hydrolysis of racemic styrene
oxide with StEH has been investigated and demonstrated to be an enantioconvergent process with
initial attack on the a (benzylic) carbon atom of (S)-styrene oxide to form (R)-1-phenyl-1,2ethanediol followed by hydrolysis of the b (terminal carbon) atom of (R)-styrene oxide to form
again (R)-1-phenyl-1,2-ethanediol (Fig. 1B) (Monterde et al., 2004). Therefore, this single
enzyme was used to form (R)- 1-phenyl-1,2-ethanediol from racemic styrene oxide at 86%
enantiomeric excess at 100% conversion (Monterde et al.,
2004) although the rate is 300-fold slower for the (R)-styrene oxide reaction. A mixture of EHs
from the fungi Aspergillus niger and Beauveria sulfurescens have also been used for the
enantioconvergent synthesis of (R)-1-phenyl-1,2-ethanediol from racemic styrene oxide (Archelas
and Furstoss, 1998). Here, we report the conversion of racemic styrene oxide to pure (R)-1phenyl-1,2-ethanediol using a mixture of StEH, which produces (R)-1-phenyl-1,2-ethanediol from
both (R)-and (S)-styrene oxide, and EchA-I219F, which converts (R)-styrene oxide to (R)-1phenyl-1,2-ethanediol rapidly with slow conversion of (S)-styrene oxide to (S)-diol (Rui et al.,
2005) (Fig. 1). This is the first report of combining an EH from plant and bacterial sources for
enhancing the enantioselectivity toward a racemic compound with the result: a more rapid
enzyme system with both higher enantiomeric excess and yield of (R)-phenyl-1,2-ethanediol was
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created.
MATERIALS AND METHODS
Chemicals, Organisms, and Cultivation
Racemic styrene oxide, (R)-styrene oxide, and (S)-styrene oxide were purchased from
Sigma Chemical Co. (St. Louis, MO); all the other chemicals were obtained from Fisher
Scientific Company (Pittsburgh, PA). Escherichia coli strain TG1 (Sambrook et al., 1989) was
used as the host for cloning and functional expression of genes from the pBS(Kan) plasmids. E.
coli strain BL21(DE3)plysS and BL21-CodonPlus(DE3)-RIPL strain (Stratagene, La Jolla, CA)
were utilized as the hosts for expression and purification of the His-tag fusion proteins. All the
strains were routinely cultivated at 37°C in Luria–Bertani (LB) broth (Sambrook et al., 1989)
supplemented with appropriate antibiotics (Table 1). All experiments performed (unless otherwise
stated) by whole cells or sonicated cells were started from single colonies, induced with 1 mM
isopropyl b-D-thiogalactopyranoside (IPTG) at an optical density at 600 nm (OD600) of 0.2–0.3,
and harvested after 2 h of IPTG induction at an OD600 of 1.5–2.0.
General Molecular Techniques
Enzymes were purchased from New England Biolabs (Ipswich, MA). Polymerase chain
reaction (PCR) products were purified by Wizard PCR Preps, plasmid DNA was isolated using a
Midi or Mini Kit (Qiagen, Inc., Chatsworth, CA), and DNA fragments were isolated from agarose
gels by using a QIAquick Gel Extraction Kit (Qiagen, Inc.). E. coli was electroporated using a
Gene Pulser/Pulse Controller (Bio-Rad Laboratories, Hercules, CA) at 15 kV/cm, 25 µF, and
200Ω. Adye terminator cycle sequencing protocol based on the dideoxy method of sequencing
DNA (Sanger et al., 1977) was used.
Cloning EH in E. coli
To stably and constitutively express the potato enzyme StEH in E. coli, an expression
cassette with a typical E. coli ribosome-binding site (AGGAGG) and an intervening region that
was used to express nitrilase in E. coli were used here (Kobayashi et al., 1992); this region was
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introduced by amplifying the gene encoding StEH from pEH10.1 (Stapleton et al., 1994) using
primers StEH10.1 forward 2 with StEH10.1 reverse (Table 2) (note pEH10.1 lacks a procaryotic
promoter). Following an initial denaturation at 96°C for 2 min, a thermal amplification profile of
30 cycles with denaturation at 94°C for 45 s, annealing at 52°C for 45 s, and extension at 72°C
for 1.5 min, and then a final extension at 72°C for 7 min was used. The PCR product was double
digested with SalI and BamHI and ligated into plasmid pBS(Kan) to form pBS(Kan)-StEH (Fig.
2A).
To purify both EchA-I219F and StEH using a histidine tag, genes encoding both EHs
were amplified from the pBS(Kan) vectors by PCR using primers STEH PET forward and STEH
PET reverse for StEH, and EHAD1 PET Front and EHAD1 PET Rear for EchA-I219F (Table 2)
under the same thermal amplification profile as above. The PCR products were double digested
by NdeI and HindIII, and inserted into pET28b(þ) (Novagen, Madison, WI) to generate the
pETStEH and pET-EchA-I219F (Fig. 2B and C) which yielded a six amino-acid His-tag as well
as a thrombin cleavage sites at the N-terminus of the EHs. Both of genes were sequenced
completely using primers SEQ PET forward, SEQ PET reverse, EH AD1 108 Rear, and SEQ PET
Front upstream (Table 2) to confirm there was no amino acid change in the recombinant plasmids
and to confirm the presence of the I219F mutation in EchA-I219F.
To

overexpress

the

EchA-I219F,

pET-EchA-I219F

was

transformed

into

BL21(DE3)plysS by electroporation. For pET-StEH, BL21-CodonPlus(DE3)-RIPL carrying
genes encoding extra copies of argU, ileY, leuW and proL rare codon tRNAwas used since 5 out
of 10 arginines in the StEH gene are encoded by the rare codons AGA or AGG (Stratagene).
Protein Purification
Both EchA-I219F and StEH with a His-tag were purified by Ni-NTA column (Invitrogen,
Carlsbad, CA). An overnight culture of BL21(DE3)plysS harboring pET-EchA-I219F was
exponentially grown in 25 mL LB medium with kanamycin (50 µg/mL) and chloramphenicol (34
µg/mL), then diluted 1:100 in 1 L of fresh LB medium with the same antibiotics, and incubated at
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378C. IPTG (1 mM) was added at cell OD600 about 0.3, and the culture was incubated at 37°C
overnight. One-liter cells were harvested by centrifugation at 10,000g, 4°C for 10 min and
resuspended in 10 mL of the native purification buffer (50 mM NaH2PO4, pH 8.0, 0.5 M NaCl).
Bacteria lysis was performed by passing the cell resuspension (10 mL) through a French Pressure
Cell Press (Spectronic Instruments, Rochester, NY) and centrifuged at 20,000g, 4°Cfor 1 h to
pellet the cell debris. The supernatants containing the soluble EHs were loaded into a 10-mL NiNTA column for purification. His-tagged enzymes were eluted with native purification buffer
with imidazole (250 mM) and dialyzed against TE buffer (100 mM Tris-Cl, 0.2 mM EDTA)
overnight and then dialyzed against storage buffer (10 mM Tris-SO4, 1 mM EDTA, 1 mM
bmercaptoethanol, 0.02% sodium azide, and 20 % glycerol, pH 7.5). Purification of StEH was
performed as above except BL21-CodonPlus (DE3)-RIPL harboring pET-StEH was cultured in
LB with kanamycin (50 µg/mL), chloramphenicol (34 µg/mL), and streptomycin (50 µg/mL) for
maintaining of the pET-StEH, the pACYC-based plasmid with extra copies of the argU and proL
tRNA genes, and the pSC101-based plasmid carrying extra copies of the argU, ileY, and leuW
tRNA genes, respectively (Stratagene). The concentrations of the purified enzymes were
evaluated by comparing standard protein samples (Precision plus protein standards, Bio-Rad
Laboratories) of known concentration on polyacrylamide gel electrophoresis in sodium dodecyl
sulfate (SDS–PAGE). To corroborate these values, a method based on spectrophotometric
measurement of the purified enzymes in 6 M guanidine at 280 nm was used (Edelhoch, 1967; Gill
and Hippel, 1989). Both of the methods gave similar results for the concentration of
His-EchA-I219F (1 mg/mL) and His-StEH (1 mg/mL), which was used for the calculation for the
specific activity of enzymes.
Enzyme Assays
To test initial StEH expression in E. coli harboring pBS(Kan)-StEH, a spectrophotometric
method was used (Rui et al., 2005) with whole cells. Briefly, 2 mL of exponentially growing
whole cells were incubated with 5 mM racemic styrene oxide in 15 mL glass vial at 37°C for 1 h
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with shaking at 250 rpm, and then the vial was incubated at 50°Cfor 50 min after adding 1 mL of
100mM 4-(4-nitrobenzyl)-pyridine. To detect the remaining racemic styrene oxide, 1 mL of 50%
triethylamine was added to the vial (in acetone), and the absorbance of mixture was measured at
OD600.
To make the crude extract for the enzyme assays, exponentially growing cells harboring
EHs were harvested and adjusted to OD600 to 1 in TEM buffer (10 mM Tris- HCl, 1mM EDTA,
and 1 mM mercaptoethanol, pH 7.4), and the cells were sonicated 10 times for 10 s at 10 W (with
a 1-min interval on ice between two sonications) with a F60 sonic dismembrator (Fisher
Scientific, Pittsburgh, PA). The concentration of EH in the sonicated cells was estimated from
SDS–PAGE (for specific rates).
For the reactions with single purified enzymes, the hydrolysis of racemic styrene oxide,
(S)-styrene oxide, or (R)-styrene oxide was performed with 60–300 µg His-StEH and 160–320 µg
His-EchA-I219F. The enzymes were mixed in 4–10 mL TEM buffer and contacted with 5 mM of
these substrates at 37°Cwith shaking (250 rpm) for 40–60min. For the hydrolysis of racemic
styrene oxide by the mixture of EHs, His-StEH (40 µg), and His-EchA-I219F (200 µg) were
mixed in 5mLTEMbuffer and incubated with 5mMracemic styrene oxide. To investigate the
inhibition of (R)-styrene oxide hydrolysis by (R)-1-phenyl-1,2-ethanediol with StEH, (R)-1phenyl-1,2-ethanediol (2.5 mM) and 2.5 mM (R)-styrene oxide were incubated together with
purified His-StEH (80 µg) in 5mLreaction at 37°C with shaking (250 rpm) for 1h. For the control,
2.5mM (R)-styrene oxide was added to the same amount of purified His-StEH (no (R)-1-phenyl1,2-ethanediol). The initial rates of the enzymes toward the different substrates were calculated.
Identification of Products from Hydrolysis of Styrene Oxide
The reaction products were analyzed by chiral highperformance liquid chromatography
(HPLC) for the production of enantiomer of diols (Rui et al., 2005). Briefly, samples (500 µL)
were withdrawn by syringe from the reaction and quenched by extracting with 800 µL ethyl ether.
HPLC (Waters Corp., Milford, MA) including 515 HPLC pumps, a 996 photodiode array
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detector, and Millenium32 Chromatography Manager Software was used to determine the
absolute configuration of the enantiomers of 1-phenyl-1,2-ethanediol formed from hydrolyzing
styrene oxide. The (R)- and (S)-1-phenyl-1,2-ethanediol were separated by a Chiralcel OB (4.6 X
250 mm) column (Chiral Technologies, Inc., Exton, PA) using hexane/2-propanol (76/24, v/v) as
the eluent with a flow rate of 0.5 mL/min with retention times of 10.2 min and 11.2 min,
respectively. To quantify (R)- and (S)-1-phenyl-1,2-ethanediol formation and styrene oxide
remaining in the reaction, UV-visible spectra were acquired using a diode array detector
(scanning from 200 to 600 nm). The HPLC detection limit under these conditions for racemic
styrene oxide was measured using serial dilutions of racemic styrene oxide from 5 to 0.01 mM in
TEM buffer and extraction with ethyl ether.
The enantiomeric ratio was calculated based on substrate disappearance as determined by
gas chromatography (GC). Samples were prepared by withdrawing 500 µL liquid from the
reaction and extracting the styrene oxide with the same volume methlyethene chloride with 5m
Mmesitylene. A gas chromatograph (Agilent 6890 series) equipped with a 30 m X 0.25 mm
Chiraldex G-TA capillary column (Astec,Whippany, NJ) and a flame-ionization detector (FID)
was used. Hydrogen (40 mL/min) and air (400 mL/min) were supplied to the FID, and the carrier
gaswas nitrogen (0.7mL/min). Samples injected into the GC were analyzed isothermally at
225°C, and the retention times of (S)-styrene oxide and (R)-styrene oxidewere 8.16 min and 9.75
min, respectively. Concentrations were calculated by comparing the peak area with the peak area
formed by the internal standard mesitylene (5 mM). The enantioselectivity
(E) (Chen et al., 1982) = ln [(1 - C)(1 - EES)]/ln [(1 - C)(1 + EES)], where conversion (C) = 1 [styrene oxide]/[initial styrene oxide] and EES is the enantiomeric excess based on substrates =
([S-styrene oxide]-[R-styrene oxide])/([S-styrene oxide]+[R-styrene oxide]) for EchAI219F and
([R-styrene oxide]-[S-styrene oxide])/([R-styrene oxide] + [S-styrene oxide]) for StEH. The
enantiomeric ratio of each enzyme was calculated when roughly 50% of the racemic styrene
oxide was converted (C = 0.5). EEP is the enantiomeric excess based on the products = ([R-diol] 86

[S-diol])/ ([R-diol] + [S-diol]).
RESULTS
Expression of StEH in E. coli
To express StEH in a procaryotic system, pBS(Kan)-StEH was constructed by cloning the
gene for StEH into pBS(Kan) along with a suitable ribosome-binding site (Kobayashi et al.,
1992) and transformed into E. coli strain TG1 under the control of a constitutive lac promoter
(Fig. 2A). StEH with activity toward styrene oxide was obtained (162 nmol/min/mg protein for
racemic styrene oxide using whole cells). To purify both of StEH and EchA-I219F, the EH genes
were cloned into pET28b(+) by fusing the EH genes
between the NdeI and HindIII site, so that the genes were under the control of T7 promoter and a
six amino acid His-tag and thrombin site were added at the N-terminus (Fig. 2B and C).
Protein Purification
Both EHs with the His-tag at the N-terminus were purified using a Ni-NTA matrix; the
purity was checked using SDS–PAGE (Fig. 3) and the enzymes were both found to be greater
than 90% pure. Bands with approximately 37 kDa molecular weight were observed
corresponding to both His-EchA-I219F and His-StEH (predicted sizes of 36.3 kDa and 38.5 kDa,
respectively).
Conversion of Racemic Styrene Oxide by StEH and EchA-I219F
The detection limit was determined by HPLC to be 99% for racemic styrene oxide.
Purified His-StEH demonstrated a rapid rate as racemic styrene oxide was converted to (R)-1phenyl-1,2-ethanediol at an initial rate of 22 ± 1 mmol/min/mg with the corresponding
disappearance of (S)-styrene oxide; the rate of (S)-1-phenyl-1,2-ethanediol formation was 300fold lower (Table 3). Due to the 10-fold slower rate of
StEH on (R)-styrene oxide, the reaction can be made to go to completion, but it took 15 h to
convert 96 ± 4% racemic styrene oxide to diols with product enantiomeric excess of 87±4% in
favor of (R)-1-phenyl-1,2-ethanediol which agrees with the earlier report (100% conversion with
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86% enantiomeric excess) (Fig. 4A) (Monterde et al., 2004). Similar results were obtained here
by contacting crude extracts of His-StEH with racemic styrene oxide: at least 99% conversion of
substrates with 85.4 ± 0.4% enantiomeric excess.
Purified EchA-I219F was found to convert racemic styrene oxide to (R)-1-phenyl-1,2ethanediol 11 times faster than to (S)-1-phenyl-1,2-ethanediol with high rates (Table 3). Although
EchA-I219F that lacks a His-tag is more active than the wild-type enzyme (Rui et al., 2005),
purified recombinant His-EchA-I219F showed lower activity toward racemic styrene oxide
(2.0±0.2 µmol/min/mg) (Table 3) compared with the wild-type EchA that lacks a His-tag (5.2
µmol/min/mg) (Rui et al., 2005). The same discrepancy was seen with the crude extracts, which
indicates the His-tag at the N-terminus decreases the rate of reaction but did not affect
enantioselectivity (Fig. 4B).
The conversion of racemic styrene oxide by purified His-StEH and His-EchA-I219F were
also monitored by GC analysis based on the disappearance of each enantiomer of racemic styrene
oxide. The enantiomeric ratio of racemic styrene oxide hydrolysis by purified His-StEH was 40 ±
17 (Table 3), and the rate of production of (R)-1-phenyl-1,2-ethanediol from (S)-styrene oxide
hydrolysis was 17.2 ± 0.4 µmol/min/mg. This shows the preference for (S)-enantiomer
disappearance for StEH, while the His-EchA-I219F, which catalyzed primarily the hydrolysis of
the (R)-enantiomer, had an enantiomeric ratio of 10.0 ± 0.9, with the rate of (R)-1-phenyl-1,2ethanediol formation as 1.9 ± 0.1 µmol/min/mg, but only 0.17 ± 0.03 µmol/min/mg for (S)-1phenyl-1,2-ethanediol formation (Table 3).
Enantioconvergent Production of (R)-1-Phenyl-1,2-ethanediol
Since the His-StEH and His-EchA-I219F enzymes can hydrolyze (S)-styrene oxide and
(R)-styrene oxide, respectively, to (R)-phenyl-1,2-ethanediol at high rates as well as high
enantioselectivity, a mixture of purified His-StEH and His-EchA-I219F was used for hydrolyzing
racemic styrene oxide. The ratio of the purified His-StEH and His-EchAI219F to be used in the
reaction system was based on the rate of pure styrene oxide hydrolysis by each enzyme, and the
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enantiomeric ratio based on substrate disappearance. To determine the rates with purified
substrates, purified His-EchA-I219F or His- StEH was contacted with 5mM pure (S)-styrene
oxide and (R)-styrene oxide (note rates shown in Table 3 are with racemic mixtures). The rate of
(R)-phenyl- 1,2-ethanediol formation from (S)-styrene oxide by purified His-StEH was 18 ± 1
µmol/min/mg, while the rate of (R)-phenyl-1,2-ethanediol formation from (R)-styrene oxide by
His-StEH was only 1.27 ± 0.05 µmol/min/mg. For purified His-EchA-I219F, the (R)-phenyl-1,2ethanediol formation rate was 2.3 ± 0.1 µmol/min/mg which is 10-fold faster than the (S)-phenyl1,2-ethanediol formation from pure (S)-styrene oxide hydrolysis by this enzyme. Using the rates
of (R)-phenyl-1,2-ethanediol formation by the two enzymes as well as the ratio of enantiomeric
ratio (40 ± 17 vs. 10.0 ± 0.9) as a guide, the amounts of His-StEH and His-EchA-I219F enzyme
for the enantioconvergent production of (R)-1-phenyl-1,2-ethanediol from racemic styrene oxide
were 40 µg His-StEH and 200 µg His-EchAI219F. Racemic styrene oxide (5 mM) was
hydrolyzed by purified His-StEH and His-EchA-I219F to pure (R)-1-phenyl-1,2-ethanediol in 1 h
with 99.9 ± 0.1% conversion and an enantiomeric excess of the product (R)-1-phenyl-1,2ethanediol of 97.9 ± 0.2% (Fig. 4C). The initial rate of racemic styrene oxide hydrolysis was 4.7
± 0.3 µmol/min/mg, which was corroborated by the production of (R)-1-phenyl-1,2-ethanediol at
4.7 ± 0.7 µmol/min/mg (Table 3). The enantiomeric ratio of the EH mixture toward racemic
styrene oxide (calculated by monitoring substrate disappearance) was only 2.2 ± 0.3, as expected,
since each purified enzyme, His-EchA-I219F and His-StEH, reacted primarily with (R)- or (S)styrene oxide, at the same time (Fig. 4D) (werecognize this ratio has little meaning for a dual
enzyme system).
Stability of Styrene Oxide
TEM buffer and sonicated E coli TG1 or BL21-Codon-Plus(DE3)-RIPL (no enzyme)
were contacted with racemic styrene oxide (5 mM) to determine if styrene oxide decomposition
impacts the rate of racemic styrene oxide hydrolysis by the EHs. Only 4.4% of racemic styrene
oxide decomposed in TEM system after 45 min, and 10% decomposition occurred for both TG1
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and BL21-Codon-Plus(DE3)-RIPL after 2 h of incubation. Because all the experiments performed
by purified enzymes were reacted with substrates in the TEM system for less than 1 h and the
experiments performed by sonicated cells were completed within 2 h, the decomposition of
substrate had little impact on the reaction rates.
Inhibition of (R)-Styrene Oxide Hydrolysis by (R)-1-Phenyl-1,2-ethanediol With StEH
To investigate if (R)-styrene oxide hydrolysis was inhibited by the (R)-1-phenyl-1,2ethanediol formed from racemic styrene oxide degradation with His-StEH, 2.5 mM (R)-1-phenyl1,2-ethanediol and 2.5 mM (R)-styrene oxide were incubated together with purified His-StEH.
The initial rate of (R)-1-phenyl-1,2-ethanediol production from (R)-styrene oxide was similar
with the control at the beginning; however, the rate decreased by 36% after 15 min. Hence, (R)styrene oxide hydrolysis by StEH is inhibited by the product (R)-1-phenyl-1,2-ethanediol; this
causes the single potato enzyme to require large reaction times to completely convert racemic
styrene oxide to (R)-1-phenyl-1,2-ethanediol (Fig. 4A) which is the motivation for using two
enzymes.
DISCUSSION
We show clearly in this work that the mixture of EHs from a bacterial source (EchAI219F) and a plant source (StEH) produce (R)-1-phenyl-1,2-ethanediol rapidly (in 1 h) with both
high yield (99.9 ± 0.1%) and high enantiomeric excess of (R)-1-phenyl-1,2-ethanediol (97.9 ±
0.2%). This process is an improvement over previous systems which utilize StEH alone but
produce only 86% enantiomeric excess (R)-1-phenyl-1,2-ethanediol while requiring 15h
conversion time due to the slow rate of this enzyme for (R)-styrene oxide and the inhibition of
(R)-1-phenyl-1,2-ethanediol (Fig. 4A) (Monterde et al., 2004). The EchA-I219F/StEH mixture is
also better than the two fungal EH system, which produces only 89% enantiomeric excess and
requires 2h conversion time (Archelas and Furstoss, 1998).
The EchA-I219F was obtained from our previous work via active site engineering of the
wild-type EchA by introducing the phenylalanine residue into position I219, which has van der
90

Waals contact with both F108 and Y215. The substitution of phenylalanine for isoleucine shifts
the position of (R)-styrene oxide to favor the enantioselectivity toward formation of (R)-1-phenyl1,2-ethanediol (Rui et al., 2005). This enzyme is not suitable by itself for enantiomeric conversion
since it converts (S)-isomer of the racemic substrate into (S)-1-phenyl-1,2-ethanediol of the
racemic styrene oxide after consumption of (R)-isomer. EchA-I219F also does not completely
convert racemic styrene oxide (50% yield, Fig. 4B) because the conversion of the (S)-isomer of
the racemic substrate is inhibited by the (S)-diol that is formed (Rui et al., 2005). Hence, by using
two enzymes, we overcame the problems of each and converted racemic styrene oxide rapidly to
nearly pure (R)-1-phenyl-1,2- ethanediol (98% enantiomeric excess and 99% conversion).
This prevents the loss of 50% of the substrate and allows an inexpensive substrate to be
used. There is no chemical equivalent process known to date.

The authors are grateful for the gift of pEH10.1 by Dr. Belknap (United States Department of
Agriculture).
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Figure 1. Schematic of enantioselective hydrolysis of racemic styrene oxide by: (A) EchA-I219F
to form (R)-1-phenyl-1,2-ethanediol and (S)-1-phenyl-1,2-ethanediol, (B) StEH to form (R)-1phenyl-1,2-thanediol and a small amount of (S)-1-phenyl-1,2-ethanediol, and (C) a mixture of
EchA-I219F and StEH toform (R)- 1-phenyl-1,2-ethanediol only.
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Figure 2. Schematics of plasmids (A) pBS(Kan)-StEH, (B) pET-StEH, and (C) pET-EchA-I219F.
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Figure 3. SDS–PAGE to check the purification of His-I219F and His-StEH. E, crude extract; F,
flow through; and P, purified enzyme.
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Figure 4. Enantioselective hydrolysis of 5mM racemic styrene oxide by purified enzymes.
Production of (R)-1-phenyl-1,2-ethanediol from racemic styrene epoxide by: (A) purified HisStEH (160 µg in a 10mL reaction), (B) purified His-EchA-I219F (200 µg in a 5mL reaction), (C)
a mixture of purified His-StEH and His-EchA-I219F (40 µg and 200 µg, respectively in a 5 mL
reaction), and (D) disappearance of racemic styrene oxide by the mixture of enzymes (40 µg and
200 µg, respectively in a 5 mL reaction). One of two duplicate experiments shown.
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Table 1. Strains and plasmids used in this article.
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Table 2. Primers used in this work with restriction enzymes underlined and the modified
ribosome-binding site in lowercase.
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Table 3. Specific activity of His-StEH and His-EchA-I219F toward 5 mM racemic styrene
oxide.
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APPENDIX II
AN INSECT FARNESYL PHOSPHATASE HOMOLOGOUS TO THE N-TERMINAL
DOMAIN OF SOLUBLE EPOXIDE HYDROLASE
Abstract
In insects, farnesyl pyrophosphate (FPP) is converted to juvenile hormone (JH) via a
conserved pathway consisting of isoprenoid derived metabolites. The first step of this pathway is
presumed to be hydrolysis of FPP to farnesol in the ring gland. Based on alignment of putative
phosphatases from D. melanogaster with the phosphatase domain of soluble epoxide hydrolase,
Phos2680 and Phos15739 with conserved phosphatase motifs were identified, cloned and
purified. Both D. melanogaster phosphatases hydrolyzed para-nitrophenyl phosphate, however,
Phos15739 also hydrolyzed FPP with a Kcat/Km of 2.1 X 105 M−1s−1. RT-PCR analysis revealed
that Phos15739 was expressed in the ring gland and its expression was correlated with JHIII titer
during development of D. melanogaster. N-acetyl-S-geranylgeranyl-L-cysteine was found to be a
potent inhibitor of Phos15739 with an IC50 value of 4.4 μM. Thus, our data identify Phos15739 as
a FPP phosphatase that likely catalyzes the hydrolysis of FPP to farnesol in D. melanogaster.
INTRODUCTION
Juvenile hormones (JHs), the unique sesquiterprenoid hormones synthesized and secreted
by the corpora allata (CA) region of ring glands play important roles in insect embryonic
development, metamorphosis, and reproduction [1, 2]. JH is critical for insect maturation and the
concentration of JH is regulated by tissue specific rates of biosynthesis, release, and degradation
[3]. Because FPP hydrolysis to farnesol is generally considered to be the first committed step in
JH biosynthesis [2], this step may be critical in controlling endogenous JH levels and/or rates of
JH production. Insects synthesize FPP, the 15-carbon precursor of JH, dolichol, ubiquinon and
prenylated proteins, from acetyl-CoA via the classical mevalonate pathway. Thus, insect enzymes
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involved in FPP synthesis have been identified based on conservation of the mevalonate pathway
between vertebrates and insects. However, due to the apparent lack of vertebrate orthologs of
enzymes involved in the synthesis of JH from FPP, no structural data for the insect FPP
pyrophosphatase, farnesol oxidase or farnesal dehydrogenase are available [2, 5]. JH acid
methyltransferase and JH epoxidase, the last two enzymes involved in JH biosynthesis, have been
previously identified [4, 6].
Recently, the N-terminal phosphatase domain of mammalian soluble epoxide hydrolase
was reported to be in the haloacid dehalogenase superfamily [7]. Structure and sequence
alignment of mammalian sEH with phosphonoacetaldehyde hydrolase (PhAH) from Bacillus
cereus, haloacid dehalogenase (HAD) from Xanthobacter autotrophicus, and phosphoserine
phosphatase (PSP) from Methanococcus jannaschii revealed three common motifs with Asp-9 as
the catalytic nucleophile [7]. Previously, the effect of hsEH on isoprenoid phosphate hydrolysis
was evaluated in our lab. FPP was found to be a substrate of the N-terminal domain of hsEH with
a turnover number of 0.25 ± 0.07 s−1, and a series of isoprenoid-derived compounds were
identified as hsEH phosphatase inhibitors [8]. Based on the hypothesis that mammalian soluble
epoxide hydrolases evolved by fusion of the primitive haloacid dehydrogenase N-terminal
domain and the primitive haloalkane dehalogenase C-terminal domain [9], we reasoned that a
distinct and separate N-terminal phosphatase domain might exist in insects. Furthermore, due to
the uniqueness of JH biosynthesis in insects, inhibitors disrupting FPP hydrolysis to farnesol
might be of potential use as insect growth regulators.
Here, we report the identification of phosphatase candidates from the D. melanogaster
genome by comparing conserved regions of phosphatases from hsEH, PhAH, HAD and PSP.
Based on analysis of substrate specificity, localization and developmental expression, our data
suggest that Phos15739 catalyzes the hydrolysis of FPP to farnesol in D. melanogaster.
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MATERIALS AND METHODS
Chemicals and heterologous expression
All chemicals were purchased from Sigma Chemical Co. (St. Louis, MO) unless
otherwise stated. Geranylgeranyl pyrophosphate was purchased from Biomol International
(Plymouth Meeting, PA). Plasmids pFLC-1 containing the cDNA of D. melanogaster CG2680
and CG15739 were obtained from the Drosophila Genomics Resource Center. The Bac-to-Bac
Baculovirus Expression System (Invitrogen, Carlsbad, CA) was used for expressing recombinant
proteins. Sf21 insect cells were grown at 27°C in EX-CELL™420 insect serum-free medium (JRH
Biosecience, Levexa, KS) supplemented with 3% fetal bovine serum (JRH Biosecience, Levexa,
KS) and penicillin-streptomycin.
Reverse transcription
Total RNA from ring glands of early 3rd instar larva was isolated using Trizol (Invitrogen,
Carlsbad, CA, USA). The concentration and quality of the RNA samples were estimated by
measuring optical density at 260nm, 260nm/280 nm ratio and agarose gel electrophoresis. After
isolation, RNA was stored at −80°C until analyzed. RNAs were reverse transcribed with random
primers and M-MLV reverse transcriptase (Invitrogen, Carlsbad, CA, USA). Primers used for
amplifying genes encoding putative phosphatases from D. melanogaster are listed in
Supplemental Table 1. PCR conditions were 95°C for 2 min followed by 30 cycle of 95°C for 30
s; 55°C, 30 s, 72°C, 1 min; with a final extension at 72°C for 10 min.
Construction of baculoviruses expressing Phos2680 and Phos15739
The cDNAs of CG2680 and CG15739 were subcloned into pFastBac-HTa by PCR
amplification

using

primers

CG2680-v-forward:

ACGAACCAACGAATTCATGTCGCCACCACGAC-3′,
CGGCCCGCGGAA

GCTTACCTATTTTTGAATATTTTC-3′;
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CG2680-v-reverse:
CG15739-v-forward:

5′5′5′-

ACCAGAACGGGAATTCATGGC CAAACCCCAGCAC-3′, and CG15739-v-reverse: 5′TCCTCCGCCGAAGCTTGTCTAGACACG CGACTTG -3′ respectively. Following an initial
denaturation at 95°C for 1 min, an amplification profile of 30 cycles with denaturation at 95°C for
30 sec, annealing at 52°C for 30 sec, and extension at 72°C for 1 min, and then a final extension
at 72°C for 7 min was used. The PCR products were double digested with EcoR1 and HindIII and
ligated into plasmid pFactBac-HTa to form pFastBac-2680 and pFastBac-15739. The generation
of baculoviruses expressing Phos2680 and Phos15739 was performed according to
manufacturer’s instructions.
To construct the Phos15739 variant Asp28Ala (D28A), primers DM15739D28A-forward:
5′-ACCGGGTGGTCAGCGCGATCGATGGGCTTCCTG-3′ and DM15739D28A-reverse: 5′ACGCCATCGATCGCGCTGACCACCCGGTCGAAAG-3′

were

used

for

site-direct

mutagenesis. The same PCR program and method listed above were used.
Protein purification
Phos2680, Phos15739 and Phos15739-D28A with N-terminal His tags were purified on
HIS-Select Cartridges (Sigma-Aldrich; St. Louis, MO) following the manufacturer’s instructions.
His-tagged proteins were concentrated by Amicon ultra centrifugal filter devices (Millipore;
Billerica, MA). Protein concentration and purity were determined by BCA assay reagent from
Pierce (Rockford, IL) and SDS-PAGE respectively.
Enzyme assays
The specific activity of Phos2680 and Phos15739 toward p-NPP was measured in 96-well
plates. Phos2680 (50 ng) or Phos15739 (50 ng) were added in 50 μL reaction buffer (100 mM
MES, pH 6.0, 2 mM Mg 2+) containing substrate with final concentrations from 0 mM to 20 mM
at room temperature for various times, followed by adding 100 μL NaOH (0.5N) to stop the
reaction. The nitrophenol product was detected at OD405 with a SpectraMax-190 plate reader
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(Molecular Devices, Sunnyvale, CA).
The analysis of Phos2680 and Phos15739 activity using isoprenoid monophosphate and
pyrophosphate substrates was determined using PiPer Phosphate Assay Kit (Molecular Probes;
Eugene, OR) as previously described [8]. Reaction mixtures of isoprenoid mono- or
pyrophosphate substrates and Phos2680 or Phos15739 were incubated in 100 μL of reaction
buffer at room temperature for various times, followed by adding 50 μL reagent containing
EDTA, maltose, maltose phosphorylase, glucose oxidase, horseradish peroxidase, and Amplex®
Red reagent. The same assay was also used to determine whether Phos15739 was a
pyrophosphatase or monophosphatase by adding inorganic pyrophosphatase to the reaction
mixture before reagent mixture.
Inhibitors of Phos2680 and Phos15739
Inhibition assays were performed using p-NPP as substrate as described [8] with slight
modification.

N-acetyl-S-geranyl-L-cysteine,

N-acetyl-S-farnesyl-L-cysteine,

N-acetyl-S-

geranylgeranyl-L-cysteine and S-Farnesyl-thioacetic acid were pre-incubated with Phos2680 (50
ng) or Phos15739 (150 ng) for 5 min, and then reacted with 640 μM or 240 μM p-NPP in reaction
buffer (MES, 100 mM, pH 6.0, Mg2+, 2 mM). The reaction was stopped by adding 200 μL of 0.5
N NaOH and absorbance was measured at 405 nm.
TLC identification of products from hydrolysis of FPP
Production of farnesol from FPP by Phos15739 was monitored on TLC using
hexane/ethyl-acetate (4:1) as the mobile phase [10]. A ten microliter reaction mixture of 1 mM
FPP and 400 ng Phos15739 was quenched with an equal volume of methanol at 1 min and 30
min, and loaded on the TLC plate. Pure FPP, FMP, FOH and Phos15739 were utilized as controls.
Quantitative RT-PCR (Q-RT-PCR)
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The CG15739 transcript in different development stages of Drosophila was quantified
using a 7500 Fast Real-time PCR system (Applied Biosystems, Foster City, CA). Total RNAs
were extracted from different stages of D. melanogaster and RNAs were converted to cDNAs as
described above. Q-RT-PCR was carried out in 20 μl reaction volume containing SYBR Green
Master Mix (Applied Biosystems), total RNAs, and the specific primer pairs (Supplemental Table
1). Cycling conditions were 1 cycle at 95°C for 20 s, followed by 40 cycles of 3 s at 95°C and 30
s at 60°C. Melting analysis was performed at 60°C to 95°C. Each sample was run 3 or more times
for Q-RT-PCR analyses. The mRNA expression of CG15739 gene was normalized using actin as
the endogenous control gene.
RESULTS
Homology analysis
Following release of the D. melanogaster genome sequence, eight gene encoded
products, Phos2680, Phos5567, Phos10352, Phos11291, Phos15739, Phos17294, Phos32487 and
Phos32488 were identified as putative phosphatase paralogues. Alignment of these (Fig. 1A)
showed that they had one or more conserved motifs typical of phosphatases including; 1) an
aspartic acid residue as the catalytic nucleophile, 2) a serine or threonine for binding the
phosphate group, and, 3) two aspartic acid residues thought to be important for Mg2+ binding [7,
11]. Two phosphatases (Phos17294 and Phos10352) were eliminated from further analysis
because they lacked the second serine or threonine conserved motif. CG2680 and CG15739
encoded gene products containing a DXDGV motif, the conserved sequence found in the Nterminal phosphatase domain of hsEH (Fig. 1B), while CG11291 had a less well conserved
SXDGV motif. Reverse transcription analysis suggested that 6 phosphatase genes were expressed
in early 3rd instar larva (Fig. 2A), however, only CG2680, CG11291 and CG15739 were
expressed in ring glands of early 3rd instar larva (Fig. 2B). Based on these results, Phos2680 and
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Phos15739 were selected as the most likely farnesyl phosphatase candidates.
Enzyme activity
p-NPP was initially used as a substrate to measure phosphatase activity of purified
recombinant Phos2680 and Phos15739. Both Phos2680 and Phos15739 had p-NPPphosphatase
activity, with Vmax of 36 μmol/min/mg and 6.1 μmol/min/mg, with corresponding Km values of
640 μM and 240 μM respectively (Supplemental Table 2). Phos2680 and Phos15739 were Mg2+dependent and had maximum p–NPP activity at pH 6.0 (data not shown).
Since the N-terminal domain of hsEH was reported to be a phosphatase with isoprenoid
mono- and pyrophosphate hydrolysis activity [8], different isoprenoid mono- and pyrophosphates
were also utilized as substrates for Phos2680 and Phos15739. The kinetics of Phos2680 toward
most of the isoprenoid mono- and pyrophosphates substrates except IMP could not be determined
with the concentration ranges used. IMP was a good substrate for Phos2680 with Km of 35 μM
and Vmax of 59 μmol/min/mg. Unlike Phos2680, Phos15739 catalyzed hydrolysis of most of the
isoprenoid mono- and pyrophosphates substrates and had a high turnover rate and Vmax. The 20carbon substrates GGMP and GGPP, however, were not good substrates (Table 1). GMP was the
best Phos15739 substrate with Kcat/Km of 18 X 105 M−1 s−1. IMP, FMP and FPP were also good
substrates with Kcat/Km of 1.2 X 105, 3.1 X 105, 2.1 X 105 M−1 s−1 respectively. IPP and GPP
were considered to be weak substrates compared with the other mono- and pyrophosphates
analyzed.
For all the isoprenoid pyrophosphates substrates used, we found no evidence of
pyrophosphate release from Phos15739 catalyzed reactions (data not shown). Thus we conclude
that Phos15739 is a phosphatase rather than a pyrophosphatase. The final product of FPP
hydrolysis by Phos15739 was confirmed to be farnesol using thin layer chromatography (Fig. 3).
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To identify the catalytic nucleophile of Phos15739, the Asp-28 of Phos15739 was
mutated to Ala-28 to generate variant Phos15739D28A. The enzymatic activity of purified
Phos15739D28A was then measured using p-NPP and FPP as substrates. No activity was detected
with either substrate under the same reaction conditions as the positive control Phos15739 (data
not shown).
Inhibitors of Phos2680 and Phos15739
Because of similarities of Phos2680 and Phos15739 with the N-terminal domain of hsEH,
five previously used inhibitors of the N- terminal phosphatase domain of hsEH [8, 12] were
evaluated with both Phos2680 and Phos15739. S-Farnesyl-thioacetic acid and N-acetyl-Sgeranylgeranyl-L-cysteine were good inhibitors of Phos2680 with IC50 values of 5.1 ± 1.4 and 14
± 1.9 μM respectively (Table 2). For Phos15739, N-acetyl-S-geranylgeranyl-L-cysteine (IC50 of
4.4 ± 2.0 μM) was the best inhibitor of the compounds tested (Table 2), followed by N-acetyl-Sgeranyl-L-cysteine and N-acetyl-S-farnesyl-L-cysteine (IC50 = 6.3 ± 1.7 and 28 ± 6.8 μM
respectively). However, S-Farnesyl-thioacetic acid and taurolithocholic acid 3-sulfate were poor
inhibitors of Drosophila Phos15739. N-acetyl-S-farnesyl-L-cysteine was previously found to be
the best inhibitor of hsEH, indicating inhibitor selectively among Phos2680, Phos15739 and
hsEH.
Stage-Specific Expression of CG15739
To analyze the developmental regulation of CG15739 expression, CG15739 transcript
levels were monitored using Q-RT-PCR. In the developmental stages we evaluated, CG15739
transcript level changes were correlated with previously published JH titer levels (Fig. 4). Setting
expression levels of second instar larvae as 1.0, transcript expression levels of 3 rd early larvae
decreased to 0.4, and were barely detectable in 3rd instar wondering larvae and pupae (0.1 for
both) corresponding to low JH titer. On the other hand, the highest CG15739 transcript levels
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were detected in adult (male 5.2, female 3.0), at the time of maximal JHIII titer [13].
DISCUSSION
Identifying enzymes involved in the conversion of farnesyl pyrophosphate to JH has been
difficult due to the apparent lack of this pathway in vertebrates. Recently, an ortholog of the
Bombyx mori methyltransferase which converts farnesoic acid to methyl farnesonate was
identified in the Aedes expressed sequence tags (ESTs) collection [4], and a cytochrome P450
(CYP15A1) catalyzing stereoselective expoxidation of methyl farnesonate to JHIII in the CA of
the cockroach was found using ESTs from the CA of Diploptera punctata [6]. ESTs from D.
punctata, Aedes aegypti and Anopheles albimanus were compared to find potential genes
encoding enzymes involved in juvenile hormone biosynthesis. Only one enzyme, Anopheles
orthology EAA01914, was predicted to have activity capable of converting FPP to farnesol [14].
However, sequences from D. melanogaster producing significant alignments with Anopheles
EAA01914 show homology to trans-isoprenyl diphosphate synthases including farnesyl
diphosphate synthases and geranylgeranyl diphosphate synthases, enzymes catalyzing the
elongation of isoprenoid substrates to produce prenyl diphosphates.
The genome of D. melanogaster harbors several genes with protein products predicted to
be phosphatases. In our study, Phos2680 and Phos15739 were selected as the two most likely
candidates for catalyzing FPP hydrolysis based on amino acid sequence analysis of these proteins
with subclass I of the haloacid dehalogenase (HAD) superfamily including mammalian sEH,
HAD, PSP, and PhAH [7, 15]. Genes CG2680 and CG15739 encode phosphatases displaying the
three typical conserved motifs (motif I: DXDX[T/V][L/V]; motif II: [S/T]XX; and motif III: K[G/S][D/S]XXX[D/N]) for nucleophile attack, substrate binding, and Mg2+ binding respectively
[16] (Fig. 1B). Both CG2680 and CG15739 were also observed in the ring gland of D.
melanogaster using reverse transcription PCR. Six other putative phosphatases from D.
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melanogaster were eliminated from further analysis because of a lack of structural motifs or nondetectable expression in ring glands.
Variant Phos15739D28A was generated by substituting residue Asp-28, the equivalent of
hsEH Asp-9, with Ala. The purified mutant Phos15739D28A exhibited no p-NPP or FPP activities
(data not shown), consistent with our hypothesis that Asp-28 located in motif I is the catalytic
nucleophile of the enzyme.
Although both Phos2680 and Phos15739 showed high catalytic activity using p-NPP, only
Phos15739 efficiently hydrolyzed FPP and released monophosphate from the reaction.
Previously, the enzyme thought to catalyze hydrolysis of FPP to farnesol was thought to be a
pyrophosphatase, which releases pyrophosphate directly from FPP [2]. Our data show that
Phos15739 is a mono-phosphatase which hydrolyzes FPP to FMP then to farnesol.
Since FPP is a key intermediate for JH biosynthesis, a balance between synthesis and
hydrolysis of FPP seems critical. In insects, IPP is converted to dimethylallyl diphosphate
(DMAPP) by isopentenyl-diphosphate isomerase, followed by the condensation of IPP (5-carbon)
into DMAPP and sequentially to GPP (10-carbon) and FPP (15-carbon) by farnesyl diphosphate
synthetase [14]. Although IPP and GPP were substrates of Phos15739, the lower Km/Kcat of
Phos15739 with IPP (0.027 X105 M−1 s−1) and GPP (0.39 X105 M−1 s−1) suggest these compounds
are rather poor substrates. On the other hand, both FMP and FPP are approximately 10-fold better
substrates for Phos15739 with Km/Kcat of 3.1X105 and 2.1 X105 M−1 s−1 (Table 1).
Six forms of JH sharing a similar synthesis pathway have been identified and
characterized in insects, and the relative level of JHs in insects is one of the major factors
regulating insect development and metamorphosis [17]. The regulation of JH titer is therefore
critical for insect maturation and thus this pathway is an attractive target for insecticide
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development [5]. We identified Phos15739 as an insect FPPase and therefore insecticide target by
aligning Drosophila phosphatases with the N-terminus of hsEH, however, the effect of various
inhibitors on the hsEH phosphatase and Phos15739 were surprisingly different. In our study, Nacetyl-S-geranylgeranyl-L-cysteine with an IC50 value of 4.4 μM was the best inhibitor of
Phos15739. N-acetyl-S-farnesyl-L- cysteine, the best isoprenoid-derived inhibitor (IC50 as 0.84
μM) [8], and taurolithocholic acid 3-sulfate the best sulfate inhibitor for the hsEH N-terminal
phosphatase (IC50 equal to 5 μM) [12], however, had IC50 values of 28 and over 100 μM for
Phos15739. Optimizing inhibitors of Phos15739 using N-acetyl-S-geranylgeranyl-L-cysteine as a
lead compound may provide a means of disrupting JH biosynthesis and consequentially inducing
premature metamorphosis or preventing reproduction in insects.
The ring gland, the endocrine/neurohaemal organ of insects, includes two lateral
prothoracic glands, corpus cardiacum and corpus allatum (CA). The CA is considered the likely
site of synthesis and secretion of JH in D. melanogaster [18]. The expression of Phos15739 in
ring glands was confirmed by RT-PCR using cDNA synthesis from ring glands as template.
Therefore, to the best of our knowledge, Phos15739 is the first FPP mono-phosphatase that has
been confirmed to be expressed in ring glands.
In D. melanogaster, the titre of JHIII decreases from a high level in 2nd instar larvae to
relative lower levels in 3rd instar larvae, and is undetectable in early pupa [13]. In adult females,
JH is again synthesized as it is required to activate ovary maturation during reproduction [19, 20].
In males, JH has been shown to play an important role for protein synthesis in accessory glands
[21]. Mated males have 3-fold more JH and released twice as much sex pheromone as virgin
males, suggesting that JH is involved in the development of sexual signaling, promoting male
mating behavior and reproductive maturity [22]. In our study, CG15739 expression was detected
in ring glands, and high levels of transcript were detected in 2nd instar larvae and adults, whereas
relatively lower levels of transcript were detected in 3rd instar wondering larvae and pupae of D.
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melanogaster (Fig. 4). Our study also showed that expression levels of Phos15739 protein were
correlated with previously reported JHIII levels. A peak of Phos15739 appeared in 2 nd instar
larvae, and decreased in the wondering stage, followed by very low expression in the pupal stage.
Because JH titer is determined by its rate of biosynthesis, release, and degradation [3] our results
suggest that Phos15739 might be important in regulating JH levels in vivo.
In summary, we show that Phos15739 from D. melanogaster is localized in the ring gland
and hydrolyzes FPP to farnesol. The coordinated expression of CG15739 with JH titer during
development suggests a potential regulatory role in JH biosynthesis. Inhibition of this enzyme in
vivo will be important for understanding its role in regulating JH levels and, potentially for insect
control.
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Figure 1: Sequence alignment of eight putative phosphatases from D. melanogaster (A) and
sequence alignment of Phos15739, Phos2680 with N-terminal domain of hsEH (B). Boxes
indicate the three phosphatase motifs as described by Cronin (7), and bold letters indicate the
potential conserved residues in each motif.
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Figure 2: RT-PCR analysis of putative phosphatase gene expression in 3rd instar Drosophila
melanogaster larvae. (A) RT-PCR using total RNA isolated from 3rd early instar larvae as
template, primers are listed in supplemental table 1. From left to right: CG15739 (703 bp),
CG5567 (933 bp), CG11291 (795 bp), CG32487 (697 bp), CG32488 (612 bp), and CG2680 (962
bp). (B) Expression of putative phosphatases in the ring glands of 3rd instar larvae by RT-PCR.
From left to right: CG2680, CG5567, CG11291, CG15739, CG32487, and CG32488.
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Figure 3: Thin-layer chromatography showing the production of farnesol from FPP by
Phos15739. FPP (1 mM, 10 μL), FMP (1 mM, 10 μL), Farnesol (FOH, 1 mM, 10 uL), and
Phos15739 (E, 400 ng in 10 μL) were used as standards. FPP and Phos15739 (E + FPP, 400ng
and 10 μL of 1 mM respectively) were incubated at room temperature for 1 min or 30 min before
loading. The mobile phase was hexane/ethyl acetate (4:1).
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Figure 4: Comparative expression of CG15739 in different developmental stages of Drosophila
melanogaster by Q-RT-PCR. 2nd, 2nd instar larvae; 3E, 3rd instar early stage; 3W, 3rd instar
wondering stage; pupa, pupae collected with first 4 hr; female and male adult, adult samples
collected after eclosion.
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Table 1. Phosphatase activity of Phos15739 with isoprenoid mono- and pyrophosphate
substrates.
Substrate Km (μM±S.E.) Vmax (μmol.min−1mg−1±S.E.) Kcat (s−1±S.E.) Kcat/Km (M−1 s−1)
IMP

84 ± 27

18 ± 2.7

10 ± 1.5

1.2 × 105

GMP

81 ± 6.7

250 ± 9.3

140 ± 5.3

18 × 105

FMP

160 ± 20

85 ± 4.2

49 ± 2.4

3.1 × 105

GGMPa

>1000a

NDa

NDa

NDa

IPPb

430 ± 150

2.1 ± 0.39

1.2 ± 0.22

0.027 × 105

GPPb

20 ± 8. 3

1.4 ± 1.5

0.78 ±0.09

250.39 × 105

FPPb

48 ± 13

18 ± 1.8

10 ± 1.04

2. 1 × 105

GGPPa

>1000a

NDa

NDa

NDa

a

GGMP and GGPP are poor substrates of Phos15739, kinetics could not be determined (ND)

b

Values are reported as apparent kinetics.
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Table 2. In vitro inhibition of Phos2680 and Phos15739.

Inhibitor

IC50 (μM±S.E.)
of Phos2680

IC50 (μM±S.E.)
of Phos15739

N-acetyls-geranyl-L-cysteine

>100

6.3 ± 1.7

N-acetyl-S-farnesyl-L-cysteine

>100

28 ± 6.8

N-acetyl-S-geranylgeranyl-L-cysteine

14 ± 1.9

4.4 ± 2.0

S-Farnesyl-thioacetic acid

5.1 ± 1.4

>100

Taurolithocholic acid 3-sulfate

>100

>100

p-NPP (640 μM and 240 μM) was used as the substrate for Phos2680 and Phos15739
respectively.
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Supplemental Table 1. Primers used for RT-PCR and qRT-PCR.
Primer

Sequences

DM CG2680RTPCR- F2

5’- TTG TTA GGC AGC CGC TAA GT -3’

DM CG2680RTPCR-R2

5’- AAC CAG CAT CCA ATT CGT TC -3’

DM CG5567RTPCR-F2

5’- CGT CCA GTT CCT TGG TGA TT -3’

DM CG5567RTPCR-R2

5’- CCC AGG AAG TTG CGT TAC AT -3’

DM CG11291RTPCR-F2

5’- GCG ACC GGA AGT TTA AGA AG -3’

DM CG11291RTPCR-R2

5’- CAG CTG TTC AGC TTT TGA GC -3’

DM CG15739RTPCR-F2

5’- GTG GCC AAG GAA GTG AAC AT -3’

DM CG15739RTPCR-R2

5’- GGG GTA TCC CAA AGT TCG AT -3’

DM CG32487RTPCR-F2

5’- TCG ATG CAC ATG TAC GGA TT -3’

DM CG32487RTPCR-R2

5’- AGA CTT TCC AGA AGC GTG GA -3’

DM CG32488RTPCR-F2

5’- GAT CTG CTG CAC TTC CTT CG -3’

DM CG32488RTPCR-R2

5’- CCA ATT TCC TGG CTG TCA AA -3’

DM CG15739RTPCR- Forward

5’-TCT GAC CTT CCT GAC CAA CA-3’

DM CG15739RTPCR-Reverse

5’-AGT CCC TCG AAC TTG ATG CT-3’

Actin 42 Forward

5’- GGC GTG GTC GTT CCT CAT C-3’

Actin 42 Reverse

5’- TCT GAA GGA GCG GAA GTG TTG-3’
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Supplemental Table 2. Phosphatase activity of Phos15739 and Phos2680 with p-nitrophenyl
phosphate.
Km
(µM±S.E.)

Vmax
(µmol.min-1mg-1±S.E.)

Kcat
(s-1±S.E.)

Kcat/Km
(M-1 s-1)

Phos15739

240 ± 38

6.1± 0.29

3.4 ± 0.16

1.4 X 104

Phos2680

640 ± 71

36 ± 1.6

23 ± 1

3.6 X 104
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